{
	"name": "Drug",
	"properties": {
		"Name": "Drug",
		"EntityType": "TABLE",
		"Namespace": {
			"DatabaseName": "Genomics_cxj"
		},
		"Description": "A Pharmaceutical 'product' is a product that has undergone all stages of production, including packaging in its final container and labeling.  It is a good or item capable of satisfying a need or a want that is offered to a target market for attention, acquisition, use or consumption.      \n\nThe finished dosage form that contains a drug substance, generally, but not necessarily in association with other active or inactive ingredients. \n\nA drug is defined as: \n- A substance recognized by an official pharmacopoeia or formulary. \n\n- A substance intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease. \n\n- A substance (other than food) intended to affect the structure or any function of the body. \n\n- A substance intended for use as a component of a medicine but not a device or a component, part or accessory of a device. \n\nA product number is assigned to each drug product associated with an NDA (New Drug Application).  If a drug product is available in multiple strengths, there are multiple product numbers.\n\nBiologic products are included within this definition and are generally covered by the same laws and regulations, but differences exist regarding their manufacturing processes (chemical process vs. biological process.) \n\nA finished dosage form (e.g. tablet, capsule, or solution) that contains the active drug ingredient usually combined with inactive ingredients.\n\nEach product has its own benefits, quality, brand name, and packaging that gives it its own identity and distinguishing characteristics.  \n\nEvery business or organization has business rules that define precisely what a product is.    While we intuitively know what a product is, we must quantify that knowledge and associated business rules so that consistent applications can be developed.\n\nA product typically goes through five stages of development:\n\n(1)  Idea Stage - involving a thorough evaluation of the potential product\n\n(2)  Concept Stage - determines customer acceptance by testing and presentation to consumers and distribution channel members.   Specific aspects regarding quality, dependability, reliability, warranty, packaging, service, pricing, terms of sale, sales and distribution channels, advertising and promotions are evaluated.\n\n(3)  Product Development Stage - transforms the prototype product into an actual product for mass sale.   This stage requires close interaction between both marketing and manufacturing.\n\n(4)  Test Marketing Stage - may or may not be used since it is an expensive and time-consuming process.  Test marketing involves evaluating various product options and alternatives.\n\n(5)  Commercialization - It is very expensive to launch a new product so commercialization only applies to those specific products that are actually going to be sold to the market.",
		"TableType": "EXTERNAL",
		"Origin": {
			"Type": "SPARK"
		},
		"StorageDescriptor": {
			"Columns": [
				{
					"Name": "DrugId",
					"Description": "The unique identifier of a drug.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "DrugId"
					},
					"OriginDataTypeName": {
						"TypeName": "long",
						"IsComplexType": false,
						"IsNullable": false,
						"Properties": {
							"HIVE_TYPE_STRING": "long"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "DrugName",
					"Description": "The name of the pharmaceutical product, which normally corresponds to the 'marketing name' of the Product.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "DrugName"
					},
					"OriginDataTypeName": {
						"TypeName": "string",
						"IsComplexType": false,
						"IsNullable": true,
						"Length": 128,
						"Properties": {
							"HIVE_TYPE_STRING": "string"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "NdcNumber",
					"Description": "Identification of reportable controlled substances is always based on the Food and Drug Administration's National Drug Code (NDC). The National Drug Code (NDC) used by ARCOS is an 11-character code that identifies controlled substance products.\n\nThe NDC System was originally established as an essential part of an out-of-hospital drug reimbursement program under Medicare. The NDC serves as a universal product identifier for human drugs. \n\nThe Drug Listing Act of 1972, amending the Federal Food, Drug, and Cosmetic Act, became effective February 1, 1973. Its purpose is to provide the Commissioner of the Food and Drug Administration (FDA) a current list of all drugs manufactured, prepared, propagated, compounded, or processed by a drug establishment registered under the Federal Food, Drug, and Cosmetic Act. The act requires submission of information on commercially marketed drugs and is used in the enforcement of the Federal Food, Drug, and Cosmetic Act.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "NdcNumber"
					},
					"OriginDataTypeName": {
						"TypeName": "decimal",
						"IsComplexType": false,
						"IsNullable": true,
						"Precision": 10,
						"Scale": 0,
						"Properties": {
							"HIVE_TYPE_STRING": "decimal"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "PseudoNdcNumber",
					"Description": "A code developed by DEA (ARCOS) in consultation with the ARCOS registrant which enables ARCOS registrants to report transactions involving products for which an NDC does not exist.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "PseudoNdcNumber"
					},
					"OriginDataTypeName": {
						"TypeName": "decimal",
						"IsComplexType": false,
						"IsNullable": true,
						"Precision": 10,
						"Scale": 0,
						"Properties": {
							"HIVE_TYPE_STRING": "decimal"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "WhodrugVersionId",
					"Description": "The unique identifier of a WHODrug Version.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "WhodrugVersionId"
					},
					"OriginDataTypeName": {
						"TypeName": "integer",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "integer"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "WhodrugCode",
					"Description": "The unique identifier of a WHODrug consists of a an 11-digit code.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "WhodrugCode"
					},
					"OriginDataTypeName": {
						"TypeName": "integer",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "integer"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "RxnormRxcui",
					"Description": "RxNorm Unique identifier for concept (concept ID)",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "RxnormRxcui"
					},
					"OriginDataTypeName": {
						"TypeName": "string",
						"IsComplexType": false,
						"IsNullable": true,
						"Length": 1024,
						"Properties": {
							"HIVE_TYPE_STRING": "string"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "RxnormRxaui",
					"Description": "Unique identifier for atom (RxNorm Atom ID)",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "RxnormRxaui"
					},
					"OriginDataTypeName": {
						"TypeName": "string",
						"IsComplexType": false,
						"IsNullable": true,
						"Length": 1024,
						"Properties": {
							"HIVE_TYPE_STRING": "string"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "SnomedCtConceptId",
					"Description": "The unique identifier of a SNOMED CT Concept.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "SnomedCtConceptId"
					},
					"OriginDataTypeName": {
						"TypeName": "integer",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "integer"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "UmlsCui",
					"Description": "A unique identifier assigned in UMLS for a drug concept.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "UmlsCui"
					},
					"OriginDataTypeName": {
						"TypeName": "string",
						"IsComplexType": false,
						"IsNullable": true,
						"Length": 1024,
						"Properties": {
							"HIVE_TYPE_STRING": "string"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "NdfNui",
					"Description": "A unique identifier assigned in NDF-RT for every drug concept.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "NdfNui"
					},
					"OriginDataTypeName": {
						"TypeName": "string",
						"IsComplexType": false,
						"IsNullable": true,
						"Length": 1024,
						"Properties": {
							"HIVE_TYPE_STRING": "string"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "DrugIdentificationNumber",
					"Description": "A Drug Identification Number (DIN) is a computer-generated eight digit number assigned by Health Canada to a drug product prior to being marketed in Canada. It uniquely identifies all drug products sold in a dosage form in Canada and is located on the label of prescription and over-the-counter drug products that have been evaluated and authorized for sale in Canada.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "DrugIdentificationNumber"
					},
					"OriginDataTypeName": {
						"TypeName": "integer",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "integer"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "ProductCodeName",
					"Description": "The internal code name by which the pharmaceutical product is known within the company.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "ProductCodeName"
					},
					"OriginDataTypeName": {
						"TypeName": "string",
						"IsComplexType": false,
						"IsNullable": true,
						"Length": 128,
						"Properties": {
							"HIVE_TYPE_STRING": "string"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "DrugImprintCode",
					"Description": "Imprint Code any single letter or number or any combination of letter(s) and numbers assigned by a drug firm to a specific drug product.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "DrugImprintCode"
					},
					"OriginDataTypeName": {
						"TypeName": "binary",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "binary"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "DrugCodeName",
					"Description": "The internal code name by which the pharmaceutical product is known within the company.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "DrugCodeName"
					},
					"OriginDataTypeName": {
						"TypeName": "string",
						"IsComplexType": false,
						"IsNullable": true,
						"Length": 128,
						"Properties": {
							"HIVE_TYPE_STRING": "string"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "ProductStrength",
					"Description": "The pharmaceutical product strength.\n\nEx:\n\nProduct Name = Pindolol\nProduct Strength = Tablets USP 5mg",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "ProductStrength"
					},
					"OriginDataTypeName": {
						"TypeName": "decimal",
						"IsComplexType": false,
						"IsNullable": true,
						"Precision": 18,
						"Scale": 2,
						"Properties": {
							"HIVE_TYPE_STRING": "decimal"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "ProductSize",
					"Description": "The size of the associated pharmaceutical product.\n\nEx:\n\nProduct = Adalat\nProduct Number = 88110\nNational Drug Code Number = 0028-8811-51\nSize = Bottle - 100's\nSuggested Price To Retailer = $46.51",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "ProductSize"
					},
					"OriginDataTypeName": {
						"TypeName": "decimal",
						"IsComplexType": false,
						"IsNullable": true,
						"Precision": 18,
						"Scale": 2,
						"Properties": {
							"HIVE_TYPE_STRING": "decimal"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "DrugHalflifeDays",
					"Description": "Amount of time needed for half of the amount of drug administered to be eliminated from the body.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "DrugHalflifeDays"
					},
					"OriginDataTypeName": {
						"TypeName": "integer",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "integer"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "FirstDateManufactured",
					"Description": "The date that the Product was first manufactured by the Manufacturer.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "FirstDateManufactured"
					},
					"OriginDataTypeName": {
						"TypeName": "date",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"DateFormat": "YYYY-MM-DD",
							"HIVE_TYPE_STRING": "date"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "ApprovalLetterDate",
					"Description": "An official communication from FDA to a new drug application (NDA) sponsor that allows the commercial marketing of the product.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "ApprovalLetterDate"
					},
					"OriginDataTypeName": {
						"TypeName": "date",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"DateFormat": "YYYY-MM-DD",
							"HIVE_TYPE_STRING": "date"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "AndaNewDrugApplicationNumber",
					"Description": "This six digit number is assigned by FDA staff to each application for approval to market a generic drug in the United States.\n\nAbbreviated New Drug Application (ANDA) simplified submission permitted for a duplicate of an already approved drug. ANDAs are for products with the same or very closely related active ingredients, dose form, strength, administration route, use, and labeling as a product that has already been shown to be safe and effective. \n\nWhen the patent and marketing exclusivity for a particular drug has expired, the drug may be manufactured by other companies as well. Manufacturers of these generic or \"me-too\" forms are not required to repeat the extensive preclinical and clinical testing required for new drugs. Rather, they may submit an Abbreviated New Drug Application (ANDA) documenting the bioequivalence of their formulation of the drug. The FDA reviews ANDAs to compare the generic product to the original product to ensure that comparable blood levels of active ingredients are produced. \n\nAn Abbreviated New Drug Application (ANDA) contains data that, when submitted to FDA's Center for Drug Evaluation and Research, Office of Generic Drugs, provides for the review and ultimate approval of a generic drug product. Generic drug applications are called \"abbreviated\" because they are generally not required to include preclinical (animal) and clinical (human) data to establish safety and effectiveness.  Instead, a generic applicant must scientifically demonstrate that its product is bioequivalent (i.e., performs in the same manner as the innovator drug). Once approved, an applicant may manufacture and market the generic drug product to provide a safe, effective, low cost alternative to the American public.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "AndaNewDrugApplicationNumber"
					},
					"OriginDataTypeName": {
						"TypeName": "integer",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "integer"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "BiologicLicenseApplication",
					"Description": "Biological products are approved for marketing under the provisions of the Public Health Service (PHS) Act. The Act requires a firm who manufactures a biologic for sale in interstate commerce to hold a license for the product. A biologics license application is a submission that contains specific information on the manufacturing processes, chemistry, pharmacology, clinical pharmacology and the medical affects of the biologic product. If the information provided meets FDA requirements, the application is approved and a license is issued allowing the firm to market the product.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "BiologicLicenseApplication"
					},
					"OriginDataTypeName": {
						"TypeName": "integer",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "integer"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "MechanismOfActionStatement",
					"Description": "A statement describing how a drug achieves its therapeutic effects at the cellular, tissue and organ levels as appropriate.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "MechanismOfActionStatement"
					},
					"OriginDataTypeName": {
						"TypeName": "string",
						"IsComplexType": false,
						"IsNullable": true,
						"Length": 2048,
						"Properties": {
							"HIVE_TYPE_STRING": "string"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "InteractionsStatement",
					"Description": "A statement describing drugs, foods or activities that can cause important, problematic or life-threatening interactions with the topic drug.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "InteractionsStatement"
					},
					"OriginDataTypeName": {
						"TypeName": "string",
						"IsComplexType": false,
						"IsNullable": true,
						"Length": 2048,
						"Properties": {
							"HIVE_TYPE_STRING": "string"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "PharmaceuticalDrugInteractionsStatement",
					"Description": "The drug interactions statement associated with the pharmaceutical product.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "PharmaceuticalDrugInteractionsStatement"
					},
					"OriginDataTypeName": {
						"TypeName": "string",
						"IsComplexType": false,
						"IsNullable": true,
						"Length": 2048,
						"Properties": {
							"HIVE_TYPE_STRING": "string"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "OverdoseSymptomsStatement",
					"Description": "The symptoms associated with drug overdose.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "OverdoseSymptomsStatement"
					},
					"OriginDataTypeName": {
						"TypeName": "string",
						"IsComplexType": false,
						"IsNullable": true,
						"Length": 2048,
						"Properties": {
							"HIVE_TYPE_STRING": "string"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "OverdoseActionStatement",
					"Description": "A statement regarding what to do in case of an overdose.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "OverdoseActionStatement"
					},
					"OriginDataTypeName": {
						"TypeName": "string",
						"IsComplexType": false,
						"IsNullable": true,
						"Length": 2048,
						"Properties": {
							"HIVE_TYPE_STRING": "string"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "DrugAntidoteDosageStatement",
					"Description": "A statement describing the one or more drug product antidotes dosage.\n\nEx:\n\nDrug = ISONIAZID\n\nAntidote = Pyridoxine\n\nDosage = Pyridoxine IV in the amount of INH ingested or 5gm if amount is unknown, given over 30-60 minutes.\n\nComments = Cumulative dose of pyridoxine is arbitrarily limited to 40gm in adults and 20gm in children.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "DrugAntidoteDosageStatement"
					},
					"OriginDataTypeName": {
						"TypeName": "string",
						"IsComplexType": false,
						"IsNullable": true,
						"Length": 2048,
						"Properties": {
							"HIVE_TYPE_STRING": "string"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "DrugAntidoteStatement",
					"Description": "A statement describing the one or more drug product antidotes.\n\nEx:\n\nDrug = ISONIAZID\n\nAntidote = Pyridoxine\n\nDosage = Pyridoxine IV in the amount of INH ingested or 5gm if amount is unknown, given over 30-60 minutes.\n\nComments = Cumulative dose of pyridoxine is arbitrarily limited to 40gm in adults and 20gm in children.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "DrugAntidoteStatement"
					},
					"OriginDataTypeName": {
						"TypeName": "string",
						"IsComplexType": false,
						"IsNullable": true,
						"Length": 2048,
						"Properties": {
							"HIVE_TYPE_STRING": "string"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "DrugAntidoteComments",
					"Description": "Comments regarding the one or more drug product antidotes dosage.\n\nEx:\n\nDrug = ISONIAZID\n\nAntidote = Pyridoxine\n\nDosage = Pyridoxine IV in the amount of INH ingested or 5gm if amount is unknown, given over 30-60 minutes.\n\nComments = Cumulative dose of pyridoxine is arbitrarily limited to 40gm in adults and 20gm in children.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "DrugAntidoteComments"
					},
					"OriginDataTypeName": {
						"TypeName": "string",
						"IsComplexType": false,
						"IsNullable": true,
						"Length": 1024,
						"Properties": {
							"HIVE_TYPE_STRING": "string"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "DrugAdverseReactionsStatement",
					"Description": "The approval letter statement regarding adverse reactions.\n\nEx:\n\nThe most commonly reported side effect of methoxsalen alone is nausea, which occurs with approximately 10% of all patients. This effect may be minimized or avoided by instructing the patient to take methoxsalen with milk or food, or to divide the dose into two portions, taken approximately one-half hour apart. Other effects include nervousness, insomnia, and psychological depression.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "DrugAdverseReactionsStatement"
					},
					"OriginDataTypeName": {
						"TypeName": "string",
						"IsComplexType": false,
						"IsNullable": true,
						"Length": 2048,
						"Properties": {
							"HIVE_TYPE_STRING": "string"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "BiologicProductIndicator",
					"Description": "A biologic product is any virus, serum, toxin, antitoxin, vaccine, blood, blood component or derivative, allergenic product, or analogous product applicable to the prevention, treatment, or cure of diseases or injuries.  Biologic products are a subset of \"drug products\" distinguished by their manufacturing processes (biological process vs. chemical process). In general, the term \"drugs\" includes biologic products.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "BiologicProductIndicator"
					},
					"OriginDataTypeName": {
						"TypeName": "boolean",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "boolean"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "PharmaceuticalUsageStatement",
					"Description": "A medication guide contains information for patients' understanding of how to safely use a drug product.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "PharmaceuticalUsageStatement"
					},
					"OriginDataTypeName": {
						"TypeName": "string",
						"IsComplexType": false,
						"IsNullable": true,
						"Length": 2048,
						"Properties": {
							"HIVE_TYPE_STRING": "string"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "PharmaceuticalWarningsStatement",
					"Description": "The warming statement associated with the pharmaceutical product.\n\nEx:\n\nWARNINGS - GENERAL\nA. SKIN BURNING: Serious burns from either UVA or sunlight (even through window glass) can result if the recommended dosage of the drug and/or exposure schedules are not maintained.\n\nB. CARCINOGENICITY:\n1. ANIMAL STUDIES: Topical or intraperitoneal methoxsalen has been reported to be a potent photocarcinogen in albino mice and hairless mice. However, methoxsalen given by the oral route to albino mice or by any route in pigmented mice is considerably less phototoxic or carcinogenic (Hakim et al. 196011, Pathak et al. 195912).\n2. HUMAN STUDIES: A prospective study of 1380 patients over 5 years revealed an approximately nine-fold increase in risks of squamous cell carcinoma among PUVA treated patients (Stern et al. 197913 and Stern et al. 198014). This increase in risk appears greatest among patients who are fair skinned or had pre-PUVA exposure to 1) prolonged tar and UVB treatment, 2) ionizing radiation, or 3) arsenic.\n\nIn addition, an approximately two-fold increase in the risk of basal cell carcinoma was noted in this study. Roenigk et al. 198015 studied 690 patients for up to 4 years and found no increase in the risk of non-melanoma skin cancer. However, patients in this cohort had significantly less exposure to PUVA than in the Stern et al study. Recent analysis of new data in the Stern et al.cohort (Stern et al., 199716) has shown that these patients had an elevated risk of contracting melanoma. The relative risk for melanoma in these patients was 2.3 (95 percent confidence interval 1.1 to 4.1). The risk is particularly higher in those patients who have received more than 250 PUVA treatments and in those whose treatment has spanned greater than 15 years. Some patients developing melanoma did so even after having ceased PUVA therapy over 5 years earlier. These observations indicate the need for monitoring of PUVA patients for skin tumors throughout their lives.\n\nIn a study in Indian patients treated for 4 years for vitiligo, 12 percent developed keratoses, but not cancer, in the depigmented, vitiliginous areas (Mosher,198017). Clinically, the keratoses were keratotic papules, actinic keratosis-like macules, nonscaling dome-shaped papules, and lichenoid porokeratotic-like papules.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "PharmaceuticalWarningsStatement"
					},
					"OriginDataTypeName": {
						"TypeName": "string",
						"IsComplexType": false,
						"IsNullable": true,
						"Length": 2048,
						"Properties": {
							"HIVE_TYPE_STRING": "string"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "PharmaceuticalPrecautionsStatement",
					"Description": "The precautions statement associated with the pharmaceutical product.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "PharmaceuticalPrecautionsStatement"
					},
					"OriginDataTypeName": {
						"TypeName": "string",
						"IsComplexType": false,
						"IsNullable": true,
						"Length": 2048,
						"Properties": {
							"HIVE_TYPE_STRING": "string"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "PharmaceuticalInformationForPatientsStatement",
					"Description": "The information for patients statement associated with the pharmaceutical product.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "PharmaceuticalInformationForPatientsStatement"
					},
					"OriginDataTypeName": {
						"TypeName": "string",
						"IsComplexType": false,
						"IsNullable": true,
						"Length": 2048,
						"Properties": {
							"HIVE_TYPE_STRING": "string"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "PharmaceuticalPregnancyStatement",
					"Description": "The warming statement regarding pregnant patients associated with the pharmaceutical product.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "PharmaceuticalPregnancyStatement"
					},
					"OriginDataTypeName": {
						"TypeName": "string",
						"IsComplexType": false,
						"IsNullable": true,
						"Length": 2048,
						"Properties": {
							"HIVE_TYPE_STRING": "string"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "PharmaceuticalNursingMothersStatement",
					"Description": "The warming statement regarding pregnant and nursing mother patients associated with the pharmaceutical product.\n\nEx:\n\nNURSING MOTHERS: It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when methoxsalen is administered to a nursing woman.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "PharmaceuticalNursingMothersStatement"
					},
					"OriginDataTypeName": {
						"TypeName": "string",
						"IsComplexType": false,
						"IsNullable": true,
						"Length": 2048,
						"Properties": {
							"HIVE_TYPE_STRING": "string"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "PharmaceuticalPediatricUseStatement",
					"Description": "The warming statement regarding pediatric patients associated with the pharmaceutical product.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "PharmaceuticalPediatricUseStatement"
					},
					"OriginDataTypeName": {
						"TypeName": "string",
						"IsComplexType": false,
						"IsNullable": true,
						"Length": 2048,
						"Properties": {
							"HIVE_TYPE_STRING": "string"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "PharmaceuticalDermatologicReactionsStatement",
					"Description": "The dermatologic reactions warming statement associated with the pharmaceutical product.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "PharmaceuticalDermatologicReactionsStatement"
					},
					"OriginDataTypeName": {
						"TypeName": "string",
						"IsComplexType": false,
						"IsNullable": true,
						"Length": 2048,
						"Properties": {
							"HIVE_TYPE_STRING": "string"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "PharmaceuticalHematologicReactionsStatement",
					"Description": "The hematologic reactions warming statement associated with the pharmaceutical product.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "PharmaceuticalHematologicReactionsStatement"
					},
					"OriginDataTypeName": {
						"TypeName": "string",
						"IsComplexType": false,
						"IsNullable": true,
						"Length": 2048,
						"Properties": {
							"HIVE_TYPE_STRING": "string"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "PharmaceuticalMetabolicReactionsStatement",
					"Description": "The metabolic reactions warming statement associated with the pharmaceutical product.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "PharmaceuticalMetabolicReactionsStatement"
					},
					"OriginDataTypeName": {
						"TypeName": "string",
						"IsComplexType": false,
						"IsNullable": true,
						"Length": 2048,
						"Properties": {
							"HIVE_TYPE_STRING": "string"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "PharmaceuticalOtherReactionsStatement",
					"Description": "The other reactions warming statement associated with the pharmaceutical product.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "PharmaceuticalOtherReactionsStatement"
					},
					"OriginDataTypeName": {
						"TypeName": "string",
						"IsComplexType": false,
						"IsNullable": true,
						"Length": 2048,
						"Properties": {
							"HIVE_TYPE_STRING": "string"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "PharmaceuticalOverdosageStatement",
					"Description": "The overdosage warming statement associated with the pharmaceutical product.\n\nEx:\n\nIn the event of methoxsalen overdosage, induce emesis and keep the patient in a darkened room for at least 24 hours. Emesis is beneficial only within the first 2 to 3 hours after ingestion of methoxsalen, since maximum blood levels are reached by this time.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "PharmaceuticalOverdosageStatement"
					},
					"OriginDataTypeName": {
						"TypeName": "string",
						"IsComplexType": false,
						"IsNullable": true,
						"Length": 2048,
						"Properties": {
							"HIVE_TYPE_STRING": "string"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "PharmaceuticalClinicalPharmacologyStatement",
					"Description": "A statement regarding the clinical pharmacology of the drug.\n\nEx:\n\nCLINICAL PHARMACOLOGY\nThe combination treatment regimen of psoralen (P) and ultraviolet radiation of 320-400 nm wavelength commonly referred to as UVA is known by the acronym, PUVA. Skin reactivity to UVA (320-400 nm) radiation is markedly enhanced by the ingestion of methoxsalen. The drug reaches its maximum bioavailability 1 1/2-3 hours after oral administration and may last for up to 8 hours (Pathak et al. 1974)1. Methoxsalen is reversibly bound to serum albumin and is also preferentially taken up by epidermal cells (Artuc et al. 1979)2. At a dose which is six times larger than that used in humans, it induces mixed function oxidases in the liver of mice (Mandula et al. 1978)3. In both mice and man, methoxsalen is rapidly metabolized. Approximately 95% of the drug is excreted as a series of metabolites in the urine within 24 hours (Pathak et al. 1977)4.\nThe exact mechanism of action of methoxsalen with the epidermal melanocytes and keratinocytes is not known. The best known biochemical reaction of methoxsalen is with DNA. Methoxsalen, upon photoactivation, conjugates and forms covalent bonds with DNA which leads to the formation of both monofunctional (addition to a single strand of DNA) and bifunctional adducts (crosslinking of psoralen to both strands of DNA) (Dall'Acqua et al., 19715; Cole, 19706; Musajo et al., 19747; Dall'Acqua et al., 19798). Reactions with proteins have also been described (Yoshikawa, et al., 19799).\nMethoxsalen acts as a photosensitizer. Administration of the drug and subsequent exposure to UVA can lead to cell injury. Orally administered methoxsalen reaches the skin via the blood and UVA penetrates well into the skin. If sufficient cell injury occurs in the skin, an inflammatory reaction occurs. The most obvious manifestation of this reaction is delayed erythema, which may not begin for several hours and peaks at 48-72 hours. The inflammation is followed, over several days to weeks, by repair which is manifested by increased melanization of the epidermis and thickening of the stratum corneum. The mechanisms of therapy are not known. In the treatment of vitiligo, it has been suggested that melanocytes in the hair follicle are stimulated to\n \nNDA 9-048/S-037 Page 4\nmove up the follicle and to repopulate the epidermis (Ortonne et al, 197910). In the treatment of psoriasis, the mechanism is most often assumed to be DNA photodamage and resulting decrease in cell proliferation but other vascular, leukocyte, or cell regulatory mechanisms may also be playing some role. Psoriasis is a hyperproliferative disorder and other agents known to be therapeutic for psoriasis are known to inhibit DNA synthesis.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "PharmaceuticalClinicalPharmacologyStatement"
					},
					"OriginDataTypeName": {
						"TypeName": "string",
						"IsComplexType": false,
						"IsNullable": true,
						"Length": 2048,
						"Properties": {
							"HIVE_TYPE_STRING": "string"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "PharmaceuticalIndicationsAndUsageStatement",
					"Description": "The approval letter statement of indications and usage of the drug.\n\nEx:\n\nA. Photochemotherapy (methoxsalen with long wave UVA radiation) is indicated for the symptomatic control of severe, recalcitrant, disabling psoriasis not adequately responsive to other forms of therapy and when the diagnosis has been supported by biopsy. Photochemotherapy is intended to be administered only in conjunction with a schedule of controlled doses of long wave ultraviolet radiation.\n\nB. Photochemotherapy (methoxsalen with long wave ultraviolet radiation) is indicated for the repigmentation of idiopathic vitiligo.\n\nC. Photopheresis (methoxsalen with long wave ultraviolet radiation of white blood cells) is indicated for use with the UVAR* System in the palliative treatment of the skin manifestations of cutaneous T-cell lymphoma (CTCL) in persons who have not been responsive to other forms of treatment. While this dosage form of methoxsalen has been approved for use in combination with photopheresis, Oxsoralen Ultra~ Capsules have not been approved for that use.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "PharmaceuticalIndicationsAndUsageStatement"
					},
					"OriginDataTypeName": {
						"TypeName": "string",
						"IsComplexType": false,
						"IsNullable": true,
						"Length": 2048,
						"Properties": {
							"HIVE_TYPE_STRING": "string"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "PharmaceuticalContraindicationsStatement",
					"Description": "The drug approval letter statement regarding contraindications.\n\nEx:\n\nA.  Patients exhibiting idiosyncratic reactions to psoralen compounds.\n\nB.  Patients possessing a specific history of light sensitive disease states should not initiate methoxsalen therapy. Diseases associated with photosensitivity include lupus erythematosus, porphyria cutanea tarda, erythropoietic protoporphyria, variegate porphyria, xeroderma pigmentosum, and albinism.\n\nC.  Patients exhibiting melanoma or possessing a history of melanoma.\n\nD.  Patients exhibiting invasive squamous cell carcinomas.\n\nD.  Patients with aphakia, because of the significantly increased risk of retinal damage due to the absence of lenses.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "PharmaceuticalContraindicationsStatement"
					},
					"OriginDataTypeName": {
						"TypeName": "string",
						"IsComplexType": false,
						"IsNullable": true,
						"Length": 2048,
						"Properties": {
							"HIVE_TYPE_STRING": "string"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "PharmaceuticalLaboratoryTestsStatement",
					"Description": "The approval letter statement regarding laboratory tests.\n\nEx:\n\nC. LABORATORY TESTS:\n1. Patients should have an ophthalmologic examination prior to start of therapy, and thence yearly.\n3. Patients should have the following tests prior to the start of therapy and should be retested 6-12 months\nsubsequently. Additional tests at more extended time periods should be conducted as clinically indicated.\na. Complete Blood Count (Hemoglobin or Hematocrit; White Blood Count-if abnormal, a differential\ncount).\nb. Anti-nuclear Antibodies.\nc. Liver Function Tests.\nd. Renal Function Tests (Creatinine or Blood Urea Nitrogen).",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "PharmaceuticalLaboratoryTestsStatement"
					},
					"OriginDataTypeName": {
						"TypeName": "string",
						"IsComplexType": false,
						"IsNullable": true,
						"Length": 2048,
						"Properties": {
							"HIVE_TYPE_STRING": "string"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "PharmaceuticalCarcinogenesisStatement",
					"Description": "The approval letter statement regarding carcinogenic issues.\n\nEx:",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "PharmaceuticalCarcinogenesisStatement"
					},
					"OriginDataTypeName": {
						"TypeName": "string",
						"IsComplexType": false,
						"IsNullable": true,
						"Length": 2048,
						"Properties": {
							"HIVE_TYPE_STRING": "string"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "PharmaceuticalPregnancyUsageStatement",
					"Description": "The approval letter statement regarding usage by pregnant women.\n\nEx:\n\nPregnancy Category C. Animal reproduction studies have not been conducted with methoxsalen. It is also not known whether methoxsalen can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Methoxsalen should be given to a woman only if clearly needed.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "PharmaceuticalPregnancyUsageStatement"
					},
					"OriginDataTypeName": {
						"TypeName": "string",
						"IsComplexType": false,
						"IsNullable": true,
						"Length": 2048,
						"Properties": {
							"HIVE_TYPE_STRING": "string"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "PharmaceuticalPediatricUsageStatement",
					"Description": "The approval letter statement regarding children.\n\nEx:\n\nPEDIATRIC USE:\nSafety in children has not been established. Potential hazards of long-term therapy include the possibilities of carcinogenicity and cataractogenicity as described in the Warnings Section as well as the probability of actinic degeneration which is also described in the Warnings Section.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "PharmaceuticalPediatricUsageStatement"
					},
					"OriginDataTypeName": {
						"TypeName": "string",
						"IsComplexType": false,
						"IsNullable": true,
						"Length": 2048,
						"Properties": {
							"HIVE_TYPE_STRING": "string"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "PharmaceuticalAdverseReactionsStatement",
					"Description": "The approval letter statement regarding adverse reactions.\n\nEx:\n\nThe most commonly reported side effect of methoxsalen alone is nausea, which occurs with approximately 10% of all patients. This effect may be minimized or avoided by instructing the patient to take methoxsalen with milk or food, or to divide the dose into two portions, taken approximately one-half hour apart. Other effects include nervousness, insomnia, and psychological depression.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "PharmaceuticalAdverseReactionsStatement"
					},
					"OriginDataTypeName": {
						"TypeName": "string",
						"IsComplexType": false,
						"IsNullable": true,
						"Length": 2048,
						"Properties": {
							"HIVE_TYPE_STRING": "string"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "PharmaceuticalDrugDosageAndAdministrationStatement",
					"Description": "The approval letter statement regarding drug usage and administration.\n\nEx:\n\nDRUG DOSAGE: Two capsules (10 mg each) in one dose taken with milk or in food two to four hours before ultraviolet light exposure.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "PharmaceuticalDrugDosageAndAdministrationStatement"
					},
					"OriginDataTypeName": {
						"TypeName": "string",
						"IsComplexType": false,
						"IsNullable": true,
						"Length": 2048,
						"Properties": {
							"HIVE_TYPE_STRING": "string"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "PharmaceuticalHowSuppliedStatement",
					"Description": "The approval letter statement regarding how the drug is supplied.\n\nEx:\n\n8-MOP Capsules, each containing 10 mg. of methoxsalen (8-methoxypsoralen) packaged in amber glass bottles of 50 (NDC 0187-0651-42).",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "PharmaceuticalHowSuppliedStatement"
					},
					"OriginDataTypeName": {
						"TypeName": "string",
						"IsComplexType": false,
						"IsNullable": true,
						"Length": 2048,
						"Properties": {
							"HIVE_TYPE_STRING": "string"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "DrugEfficacyStatement",
					"Description": "A statement regarding the maximum ability of a drug or treatment to produce a result regardless of dosage. A drug passes efficacy trials if it is effective at the dose tested and against the illness for which it is prescribed. In the procedure mandated by the FDA, Phase II clinical trials gauge efficacy, and Phase III trials confirm it",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "DrugEfficacyStatement"
					},
					"OriginDataTypeName": {
						"TypeName": "string",
						"IsComplexType": false,
						"IsNullable": true,
						"Length": 2048,
						"Properties": {
							"HIVE_TYPE_STRING": "string"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "ReferencedListedDrugIndicator",
					"Description": "A Reference Listed Drug is an approved drug product to which new generic versions are compared to show that they are bioequivalent. A drug company seeking approval to market a generic equivalent must refer to the Reference Listed Drug in its Abbreviated New Drug Application (ANDA).  By designating a single reference listed drug as the standard to which all generic versions must be shown to be bioequivalent, FDA hopes to avoid possible significant variations among generic drugs and their brand name counterpart.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "ReferencedListedDrugIndicator"
					},
					"OriginDataTypeName": {
						"TypeName": "boolean",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "boolean"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "EligibleForExportIndicator",
					"Description": "Indicates that the pharmaceutical product is eligible for export to foreign countries without restriction.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "EligibleForExportIndicator"
					},
					"OriginDataTypeName": {
						"TypeName": "boolean",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "boolean"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "DiscontinuedDrugIndicator",
					"Description": "A discontinued drug is a drug product that has been removed from the market in the United States for reasons other than safety or effectiveness.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "DiscontinuedDrugIndicator"
					},
					"OriginDataTypeName": {
						"TypeName": "boolean",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "boolean"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "OrphanDrugIndicator",
					"Description": "An FDA category that refers to medications used to treat diseases and conditions that occur rarely. There is little financial incentive for the pharmaceutical industry to develop medications for these diseases or conditions. \n\nOrphan drug status, however, gives a manufacturer specific financial incentives to develop and provide such medications.\n\nA designation of the FDA to indicate a therapy developed to treat a rare disease (one which afflicts a U.S. population of less than 200,000 people). \n\nBecause there are few financial incentives for drug companies to develop therapies for diseases that afflict so few people, the U.S. government offers additional incentives to drug companies (i.e. tax advantages and extended marketing exclusivity) that develop these drugs.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "OrphanDrugIndicator"
					},
					"OriginDataTypeName": {
						"TypeName": "boolean",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "boolean"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "InvestigationalNewDrugIndicator",
					"Description": "A new drug, antibiotic drug, or biological drug that is used in a clinical investigation. It also includes a biological product used in vitro for diagnostic purposes.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "InvestigationalNewDrugIndicator"
					},
					"OriginDataTypeName": {
						"TypeName": "boolean",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "boolean"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "ExperimentalDrugIndicator",
					"Description": "A drug that is not FDA licensed for use in humans, or as a treatment for a particular condition",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "ExperimentalDrugIndicator"
					},
					"OriginDataTypeName": {
						"TypeName": "boolean",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "boolean"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "ExpandedAccessDrugIndicator",
					"Description": "Some investigational drugs are available from pharmaceutical manufacturers through expanded access programs.\n\nRefers to any of the FDA procedures, such as compassionate use, parallel track, and treatment IND that distribute experimental drugs to participants who are failing on currently available treatments for their condition and also are unable to participate in ongoing clinical trials.\n\nMost human use of investigational new drugs takes place in controlled clinical trials conducted to assess safety and efficacy of new drugs. \n\nData from the trials can serve as the basis for the drug marketing application. Sometimes, patients do not qualify for these carefully-controlled trials be cause of other health problems, age, or other factors. \n\nFor patients who may benefit from the drug use but don't qualify for the trials, FDA regulations enable manufacturers of investigational new drugs to provide for \"expanded access\" use of the drug. \n\nFor example, a treatment IND (Investigational New Drug application) or treatment protocol is a relatively unrestricted study. The primary intent of a treatment IND/protocol is to provide for access to the new drug for people with a life-threatening or serious disease for which there is no good alternative treatment. \n\nA secondary purpose for a treatment IND/protocol is to generate additional information about the drug, especially its safety. Expanded access protocols can be undertaken only if clinical investigators are actively studying the experimental treatment in well-controlled studies, or all studies have been completed. \nThere must be evidence that the drug may be an effective treatment in patients like those to be treated under the protocol. \n\nThe drug cannot expose patients to unreasonable risks given the severity of the disease to be treated.\n\nExpanded access protocols are generally managed by the manufacturer, with the investigational treatment administered by researchers or doctors in office-based practice.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "ExpandedAccessDrugIndicator"
					},
					"OriginDataTypeName": {
						"TypeName": "boolean",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "boolean"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "FastTrackDrugIndicator",
					"Description": "If the FDA determines that a drug shows promise in meeting a severe, unmet medical need, it may grant the drug's sponsor a fast track designation for the development of that drug. For most drugs, the FDA has 12 months to review marketing approval documents; the FDA must review similar materials for fast-tracked drugs within 6 months.\n\nThe U.S. Food and Drug Administration is a collection of government employees responsible for ensuring that foods, drugs, and cosmetics sold in the U.S. are safe for use, and, in the case of drugs, effective as well.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "FastTrackDrugIndicator"
					},
					"OriginDataTypeName": {
						"TypeName": "boolean",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "boolean"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "DrugOffLabelUseDrugIndicator",
					"Description": "A drug prescribed for conditions other than those approved by the FDA.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "DrugOffLabelUseDrugIndicator"
					},
					"OriginDataTypeName": {
						"TypeName": "boolean",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "boolean"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "GenericProductIndicator",
					"Description": "The term generic product has somewhat different meanings in different jurisdictions. \n\nUse of this term is therefore avoided as much as possible, and the term multisource pharmaceutical product  is used instead. \n\nGeneric products may be marketed either under the approved nonproprietary name or under a brand (proprietary) name. They may be marketed in dosage forms and/or strengths different from those of the innovator products. Where the term generic product is used, it means a pharmaceutical product, usually intended to be interchangeable with the innovator product, which is usually manufactured without a license from the innovator company and marketed after expiry of the patent or other exclusivity rights.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "GenericProductIndicator"
					},
					"OriginDataTypeName": {
						"TypeName": "boolean",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "boolean"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "BrandNameDrugIndicator",
					"Description": "A brand name drug is a drug marketed under a proprietary, trademark-protected name.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "BrandNameDrugIndicator"
					},
					"OriginDataTypeName": {
						"TypeName": "boolean",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "boolean"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "GenericDrugIndicator",
					"Description": "Indicates whether the drug is a generic drug.\n\nA non-brand name drug which has the same active ingredient, strength and dosage form, and which is determined by the FDA to be therapeutically equivalent to the drug product identified in the prescription.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "GenericDrugIndicator"
					},
					"OriginDataTypeName": {
						"TypeName": "boolean",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "boolean"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "PreferredBrandDrugIndicator",
					"Description": "Brand name drugs that are clinically effective, cost effective and meet the needs of most patients.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "PreferredBrandDrugIndicator"
					},
					"OriginDataTypeName": {
						"TypeName": "boolean",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "boolean"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "NonPreferredBrandDrugIndicator",
					"Description": "Brand name drugs that do not have a generic equivalent, but have a therapeutic alternative Preferred brand drug available.\n\n- Brand name drugs not usually used as the first line of treatment\n\n - Brand name drugs that have a generic equivalent\n\n- Second-highest copayment",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "NonPreferredBrandDrugIndicator"
					},
					"OriginDataTypeName": {
						"TypeName": "boolean",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "boolean"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "SpecialtyDrugIndicator",
					"Description": "Medications classified by BCBSNC as those that generally have unique uses, require special dosing or administration, are typically prescribed by a specialist provider and are significantly more expensive than alternative drugs or therapies.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "SpecialtyDrugIndicator"
					},
					"OriginDataTypeName": {
						"TypeName": "boolean",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "boolean"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "OverTheCounterMedicationIndicator",
					"Description": "An OTC (over-the-counter) medication is any medication that can be purchased without a prescription. There are OTC medications on the market that effectively treat many common health conditions, including allergies, heartburn, and arthritis.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "OverTheCounterMedicationIndicator"
					},
					"OriginDataTypeName": {
						"TypeName": "boolean",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "boolean"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "HabitFormingDrugIndicator",
					"Description": "Indicates that the drug is habit forming.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "HabitFormingDrugIndicator"
					},
					"OriginDataTypeName": {
						"TypeName": "boolean",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "boolean"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "PrescriptionNeededIndicator",
					"Description": "Indicates that the drug requires a prescription.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "PrescriptionNeededIndicator"
					},
					"OriginDataTypeName": {
						"TypeName": "boolean",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "boolean"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "AvailableAsGenericDrugIndicator",
					"Description": "Indicates that the drug is available as a generic drug.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "AvailableAsGenericDrugIndicator"
					},
					"OriginDataTypeName": {
						"TypeName": "boolean",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "boolean"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "NaturalSourcedDrugIndicator",
					"Description": "A drug defined as a natural product that is obtained from plants, microbes, animal tissues and minerals.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "NaturalSourcedDrugIndicator"
					},
					"OriginDataTypeName": {
						"TypeName": "boolean",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "boolean"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "SyntheticDrugIndicator",
					"Description": "Drugs that are synthesized compounds and modified naturally occurring drugs.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "SyntheticDrugIndicator"
					},
					"OriginDataTypeName": {
						"TypeName": "boolean",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "boolean"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "TherapeuticAlternativeDrugIndicator",
					"Description": "Drug products that provide the same pharmacological or chemical effect in equivalent doses. Also see Formulation Substitution.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "TherapeuticAlternativeDrugIndicator"
					},
					"OriginDataTypeName": {
						"TypeName": "boolean",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "boolean"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "SugarFreeProductIndicator",
					"Description": "Indicates the associated drug/product is sugar-free.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "SugarFreeProductIndicator"
					},
					"OriginDataTypeName": {
						"TypeName": "boolean",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "boolean"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "AlcoholFreeProductIndicator",
					"Description": "Indicates that the associated drug/product is alcohol-free.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "AlcoholFreeProductIndicator"
					},
					"OriginDataTypeName": {
						"TypeName": "boolean",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "boolean"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "SulfiteContainingProductIndicator",
					"Description": "Indicates the associated drug/product contains sulfites.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "SulfiteContainingProductIndicator"
					},
					"OriginDataTypeName": {
						"TypeName": "boolean",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "boolean"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "DrugMayCausePhotosensitivityIndicator",
					"Description": "Indicates the associated drug/product may cause photosensitivity reactions.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "DrugMayCausePhotosensitivityIndicator"
					},
					"OriginDataTypeName": {
						"TypeName": "boolean",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "boolean"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "ControlledSubstanceIndicator",
					"Description": "Indicates that the drug/product is a controlled substance.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "ControlledSubstanceIndicator"
					},
					"OriginDataTypeName": {
						"TypeName": "boolean",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "boolean"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "RequiresPrescriptionIndicator",
					"Description": "Indicates the associated drug/product requires a prescription for purchase.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "RequiresPrescriptionIndicator"
					},
					"OriginDataTypeName": {
						"TypeName": "boolean",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "boolean"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "ControlledReleaseProductIndicator",
					"Description": "Indicates the associated drug/product is a controlled-release product.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "ControlledReleaseProductIndicator"
					},
					"OriginDataTypeName": {
						"TypeName": "boolean",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "boolean"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "ControlledDiffusionExtendedReleaseProductIndicator",
					"Description": "Diffusion drug release may be regulated by means of a rate-controlling membrane.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "ControlledDiffusionExtendedReleaseProductIndicator"
					},
					"OriginDataTypeName": {
						"TypeName": "boolean",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "boolean"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "ControlledDissolutionReleaseProductIndicator",
					"Description": "Dissolution is controlled by means of inert polymers that gradually break down in body fluids.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "ControlledDissolutionReleaseProductIndicator"
					},
					"OriginDataTypeName": {
						"TypeName": "boolean",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "boolean"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "OsmoticPressureSustainedReleaseProductIndicator",
					"Description": "A product containing an osmotic agent that attracts gastrointestinal fluid at a constant rate.  The attracted fluid then forces the drug out of the that tablet through a small laser-drilled orifice.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "OsmoticPressureSustainedReleaseProductIndicator"
					},
					"OriginDataTypeName": {
						"TypeName": "boolean",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "boolean"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "DelayedReleaseProductIndicator",
					"Description": "Indicates the associated drug/product is a delayed-release product.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "DelayedReleaseProductIndicator"
					},
					"OriginDataTypeName": {
						"TypeName": "boolean",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "boolean"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "DoNotCrushProductIndicator",
					"Description": "Indicates the associated drug/product should not be crushed and administered in any other form.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "DoNotCrushProductIndicator"
					},
					"OriginDataTypeName": {
						"TypeName": "boolean",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "boolean"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "SelfAdministeredDrugIndicator",
					"Description": "Drugs that do not require doctors or nurses to help you when you take them. You may be charged for these. You will need to check with your doctor or hospital regarding their policy on this.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "SelfAdministeredDrugIndicator"
					},
					"OriginDataTypeName": {
						"TypeName": "boolean",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "boolean"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "EntericCoatedProductIndicator",
					"Description": "Indicates the associated drug/product is an enteric-coated product.\n\nIn general, capsules containing sustained-release or enteric-coated particles may be opened and their contents administered on a spoonful of soft food.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "EntericCoatedProductIndicator"
					},
					"OriginDataTypeName": {
						"TypeName": "boolean",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "boolean"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "SlowReleaseProductIndicator",
					"Description": "Indicates the associated drug/product is a slow-release product.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "SlowReleaseProductIndicator"
					},
					"OriginDataTypeName": {
						"TypeName": "boolean",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "boolean"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "TimedReleaseProductIndicator",
					"Description": "Indicates the associated drug/product is a timed-release product.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "TimedReleaseProductIndicator"
					},
					"OriginDataTypeName": {
						"TypeName": "boolean",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "boolean"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "EssentialDrugProductIndicator",
					"Description": "Essential drugs are those that satisfy the health care needs of the majority of the population.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "EssentialDrugProductIndicator"
					},
					"OriginDataTypeName": {
						"TypeName": "boolean",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "boolean"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "FinishedProductIndicator",
					"Description": "A product that has undergone all stages of production, including packaging in its final container and labeling.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "FinishedProductIndicator"
					},
					"OriginDataTypeName": {
						"TypeName": "boolean",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "boolean"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "PharmaceuticalProductIndicator",
					"Description": "Any preparation for human or veterinary use that is intended to modify or explore physiological systems or pathological states for the benefit of the recipient.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "PharmaceuticalProductIndicator"
					},
					"OriginDataTypeName": {
						"TypeName": "boolean",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "boolean"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "LactoseFreeProductIndicator",
					"Description": "Indicates that the product is lactose-free.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "LactoseFreeProductIndicator"
					},
					"OriginDataTypeName": {
						"TypeName": "boolean",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "boolean"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "AgonistDrugIndicator",
					"Description": "Drugs that have both receptor affinity and intrinsic activity are called agonists.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "AgonistDrugIndicator"
					},
					"OriginDataTypeName": {
						"TypeName": "boolean",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "boolean"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "AntagonistDrugIndicator",
					"Description": "Drugs that have receptor affinity but lack intrinsic activity are called antagonists.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "AntagonistDrugIndicator"
					},
					"OriginDataTypeName": {
						"TypeName": "boolean",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "boolean"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "GalactoseFreeProductIndicator",
					"Description": "Indicates that the product is lactose-free.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "GalactoseFreeProductIndicator"
					},
					"OriginDataTypeName": {
						"TypeName": "boolean",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "boolean"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "CholinergicReceptorAgonistDrugIndicator",
					"Description": "Cholinergic means related to the neurotransmitter acetylcholine,  and is typically used in a neurological perspective. \n\nThe parasympathetic nervous system  is entirely cholinergic. Neuromuscular junctions, preganglionic neurons of the sympathetic nervous system, the basal forebrain, and brain stem complexes are also cholinergic. \n\nIn addition, the receptor for the merocrine sweat glands are also cholinergic since acetylcholine is released from post ganglionic sympathetic neurons.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "CholinergicReceptorAgonistDrugIndicator"
					},
					"OriginDataTypeName": {
						"TypeName": "boolean",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "boolean"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "CholinergicReceptorAntagonistDrugIndicator",
					"Description": "The majority of the drugs used to reduce the effects of acetylcholine inhibit specifically certain types of acetylcholine receptors and can be named cholinolytic or cholinergic antagonists. \n\nOthers inhibit acetylcholine release at the synaptic level.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "CholinergicReceptorAntagonistDrugIndicator"
					},
					"OriginDataTypeName": {
						"TypeName": "boolean",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "boolean"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "AdrenergicReceptorAgonistDrugIndicator",
					"Description": "The adrenergic receptors (or adrenoceptors) are a class of G protein-coupled receptors that are targets of the catecholamines, especially noradrenaline (norepinephrine) and adrenaline (epinephrine). Although dopamine  is a catecholamine, its receptors are in a different category.\n\nMany cells possess these receptors, and the binding of an agonist will generally cause a sympathetic response (e.g. the fight-or-flight response). For instance, the heart rate will increase and the pupils will dilate, energy will be mobilized, and blood flow diverted from other non-essential organs to skeletal muscle.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "AdrenergicReceptorAgonistDrugIndicator"
					},
					"OriginDataTypeName": {
						"TypeName": "boolean",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "boolean"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "AdrenergicReceptorAntagonistDrugIndicator",
					"Description": "An Adrenergic antagonist is a pharmaceutical substance that acts to inhibit the action of the adrenergic receptors. It is thus a type of sympatholytic.\n\nIt has the opposite effect as adrenergic agonists.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "AdrenergicReceptorAntagonistDrugIndicator"
					},
					"OriginDataTypeName": {
						"TypeName": "boolean",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "boolean"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "AntihypertensiveDrugIndicator",
					"Description": "Drugs that combat hypertension.\n\nThese are classified as:\n-  Diuretics\n-  Sympatholytics\n-  Angiotensin Inhibitors\n-  Vasodilators",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "AntihypertensiveDrugIndicator"
					},
					"OriginDataTypeName": {
						"TypeName": "boolean",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "boolean"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "DiureticDrugIndicator",
					"Description": "Diuretics cause an increase in renal sodium excretion to reduce blood pressure.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "DiureticDrugIndicator"
					},
					"OriginDataTypeName": {
						"TypeName": "boolean",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "boolean"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "AntianginalDrugIndicator",
					"Description": "Antianginal drugs seek to restore the balance between myocardial oxygen supply and demand,, either by increasing oxygen supply or decreasing oxygen demand.\n\nAntianginal drugs are classified as:\n- Vasodilators\n- Beta-Adrenergic Receptor Antagonists",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "AntianginalDrugIndicator"
					},
					"OriginDataTypeName": {
						"TypeName": "boolean",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "boolean"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "AntiarrhythmicDrugIndicator",
					"Description": "Antiarrhythmic drugs help control or moderate the heartbeats.\n\nThey are classified as:\n-  Sodium Channel Blockers Class 1\n-  Sodium Channel Blockers Class 1A\n-  Sodium Channel Blockers Class 1B\n-  Sodium Channel Blockers Class 1C\n-  Sodium Channel Blockers Class II\n-  Sodium Channel Blockers Class III\n-  Sodium Channel Blockers Class IV",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "AntiarrhythmicDrugIndicator"
					},
					"OriginDataTypeName": {
						"TypeName": "boolean",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "boolean"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "HyperlipidemiaDrugIndicator",
					"Description": "Hyperlipidemia drugs are used control cholesterol.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "HyperlipidemiaDrugIndicator"
					},
					"OriginDataTypeName": {
						"TypeName": "boolean",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "boolean"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "HematopoieticDrugIndicator",
					"Description": "Hematopoietic drugs address anemia or similar blood deficiencies.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "HematopoieticDrugIndicator"
					},
					"OriginDataTypeName": {
						"TypeName": "boolean",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "boolean"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "AnticoagulantDrugIndicator",
					"Description": "An anticoagulant is a substance that prevents coagulation; that is, it stops blood from clotting.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "AnticoagulantDrugIndicator"
					},
					"OriginDataTypeName": {
						"TypeName": "boolean",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "boolean"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "AntiplateletDrugIndicator",
					"Description": "An antiplatelet drug is a member of a class of pharmaceuticals  that decreases platelet aggregation and inhibits thrombus formation",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "AntiplateletDrugIndicator"
					},
					"OriginDataTypeName": {
						"TypeName": "boolean",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "boolean"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "FibrinolyticDrugIndicator",
					"Description": "Fibrinolysis is the process wherein a fibrin clot, the product of coagulation, is broken down.\n\nIts main enzyme  plasmin  cuts the fibrin mesh at various places, leading to the production of circulating fragments that are cleared by other proteases  or by the kidney  and liver.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "FibrinolyticDrugIndicator"
					},
					"OriginDataTypeName": {
						"TypeName": "boolean",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "boolean"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "SedativeHypnoticAnxiolyticDrugIndicator",
					"Description": "A sedative is a drug that reduces a persons response to external stimuli and causes drowsiness.\n\nA hypnotic drug is a sedative that induces sleep.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "SedativeHypnoticAnxiolyticDrugIndicator"
					},
					"OriginDataTypeName": {
						"TypeName": "boolean",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "boolean"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "AntiepilepticDrugIndicator",
					"Description": "Antiepileptic drugs are medicines that reduce the frequency of epileptic  seizures.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "AntiepilepticDrugIndicator"
					},
					"OriginDataTypeName": {
						"TypeName": "boolean",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "boolean"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "NeurodegenerativeDrugIndicator",
					"Description": "Neurodegeneration is the umbrella term for the progressive loss of structure or function of neurons, including death of neurons.\n\nMany neurodegenerative diseases including Parkinson's, Alzheimer's, and Huntington's occur as a result of neurodegenerative processes.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "NeurodegenerativeDrugIndicator"
					},
					"OriginDataTypeName": {
						"TypeName": "boolean",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "boolean"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "PsychotherapeuticDrugIndicator",
					"Description": "Drugs that address psychiatric disorders such as schizophrenia.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "PsychotherapeuticDrugIndicator"
					},
					"OriginDataTypeName": {
						"TypeName": "boolean",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "boolean"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "OpioidAnalgesicDrugIndicator",
					"Description": "An opioid is a chemical that works by binding to opioid receptors, which are found principally in the central nervous system and the gastrointestinal tract. \n\nThe receptors in these two organ systems mediate both the beneficial effects and the side effects of opioids.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "OpioidAnalgesicDrugIndicator"
					},
					"OriginDataTypeName": {
						"TypeName": "boolean",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "boolean"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "LocalAnestheticDrugsIndicator",
					"Description": "Local anesthesia is any technique to render part of the body insensitive to pain  without affecting consciousness.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "LocalAnestheticDrugsIndicator"
					},
					"OriginDataTypeName": {
						"TypeName": "boolean",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "boolean"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "GeneralAnestheticDrugsIndicator",
					"Description": "A general anesthesia is a state of total unconsciousness resulting from general anesthetic drugs",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "GeneralAnestheticDrugsIndicator"
					},
					"OriginDataTypeName": {
						"TypeName": "boolean",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "boolean"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "RespiratoryTractDisorderDrugIndicator",
					"Description": "A drug addressing disorders of the respiratory tract such as asthma, chronic obstructive pulmonary disease, allergic rhinitis, virial rhinitis etc.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "RespiratoryTractDisorderDrugIndicator"
					},
					"OriginDataTypeName": {
						"TypeName": "boolean",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "boolean"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "GastrointestinalTractDisorderDrugIndicator",
					"Description": "Functional disorders are those in which the bowel looks normal but doesn't work properly. They are the most common problems affecting the colon and rectum.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "GastrointestinalTractDisorderDrugIndicator"
					},
					"OriginDataTypeName": {
						"TypeName": "boolean",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "boolean"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "HeadacheDisorderDrugIndicator",
					"Description": "Drugs used to address headaches.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "HeadacheDisorderDrugIndicator"
					},
					"OriginDataTypeName": {
						"TypeName": "boolean",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "boolean"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "PainInflammationDrugIndicator",
					"Description": "Drug used to control inflammation and pain.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "PainInflammationDrugIndicator"
					},
					"OriginDataTypeName": {
						"TypeName": "boolean",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "boolean"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "ArthriticDisorderDrugIndicator",
					"Description": "Arthritis is a joint disorder featuring inflammation. A joint is an area of the body where two different bones meet. A joint functions to move the body parts connected by its bones. Arthritis literally means inflammation of one or more joints.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "ArthriticDisorderDrugIndicator"
					},
					"OriginDataTypeName": {
						"TypeName": "boolean",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "boolean"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "HypothalamicPituitaryDrugIndicator",
					"Description": "The hypothalamus can be considered the coordinating center of the endocrine system. It consolidates signals derived from upper cortical inputs, autonomic function, environmental cues such as light and temperature, and peripheral endocrine feedback. In turn, the hypothalamus delivers precise signals to the pituitary gland which then releases hormones that influence most endocrine systems in the body.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "HypothalamicPituitaryDrugIndicator"
					},
					"OriginDataTypeName": {
						"TypeName": "boolean",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "boolean"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "ThyroidDrugIndicator",
					"Description": "he thyroid gland is located on the front part of the neck below the thyroid cartilage.\n\nThe gland produces thyroid hormones, which regulate body metabolism. Thyroid hormones are important in regulating body energy, the body's use of other hormones and vitamins, and the growth and maturation of body tissues.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "ThyroidDrugIndicator"
					},
					"OriginDataTypeName": {
						"TypeName": "boolean",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "boolean"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "AdrenalSteroidDrugIndicator",
					"Description": "The adrenal cortex is a factory for steroid hormones. In total, at least two to three dozen different steroids are synthesized and secreted from this tissue, but two classes are of particular importance.\n\nAdditionally, the adrenal cortex produces some sex steroids, particularly androgens, a talent of considerable importance in such diseases as congenital adrenal hyperplasia.\n\nLike all steroids, adrenal \"corticosteroids\" are synthesized from cholesterol through a series of enzyme-mediated transformations.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "AdrenalSteroidDrugIndicator"
					},
					"OriginDataTypeName": {
						"TypeName": "boolean",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "boolean"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "FertilityReproductionDrugIndicator",
					"Description": "Drug used for fertility and reproduction diseases and dysfunctions.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "FertilityReproductionDrugIndicator"
					},
					"OriginDataTypeName": {
						"TypeName": "boolean",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "boolean"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "DiabetesMellitusDrugIndicator",
					"Description": "Diabetes is a condition in which a person has a high blood sugar (glucose) level, either because the body doesn't produce enough insulin, or because body cells don't properly respond to the insulin that is produced. \n\nInsulin is a hormone produced in the pancreas  which enables body cells to absorb glucose, to turn into energy. If the body cells do not absorb the glucose, the glucose accumulates in the blood (hyperglycemia), leading to vascular, nerve, and other complications.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "DiabetesMellitusDrugIndicator"
					},
					"OriginDataTypeName": {
						"TypeName": "boolean",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "boolean"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "CalciumAndBoneDrugIndicator",
					"Description": "Indicates whether the drug is used to treat conditions involving calcium and bone.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "CalciumAndBoneDrugIndicator"
					},
					"OriginDataTypeName": {
						"TypeName": "boolean",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "boolean"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "AntimycobacterialDrugIndicator",
					"Description": "An antimycobacterial is a type of drug used to treat Mycobacteria infections.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "AntimycobacterialDrugIndicator"
					},
					"OriginDataTypeName": {
						"TypeName": "boolean",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "boolean"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "AntibacterialDrugIndicator",
					"Description": "A drug that destroys bacteria or suppresses their growth or their ability to reproduce.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "AntibacterialDrugIndicator"
					},
					"OriginDataTypeName": {
						"TypeName": "boolean",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "boolean"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "AntifungalDrugIndicator",
					"Description": "An antifungal drug is a medication used to treat fungal infections  such as athlete's foot, ringworm, candidacies, serious systemic infections such as cryptococcal  meningitis, and others.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "AntifungalDrugIndicator"
					},
					"OriginDataTypeName": {
						"TypeName": "boolean",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "boolean"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "AntiviralDrugIndicator",
					"Description": "Antiviral drugs are a class of medication used specifically for treating viral infections.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "AntiviralDrugIndicator"
					},
					"OriginDataTypeName": {
						"TypeName": "boolean",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "boolean"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "AntiparasiticDrugIndicator",
					"Description": "Antiparasitics are a class of medications which are indicated for the treatment of parasitic diseases such as nematodes, cestodes, trematodes, infectious protozoa, and amoebas.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "AntiparasiticDrugIndicator"
					},
					"OriginDataTypeName": {
						"TypeName": "boolean",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "boolean"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "AntineoplasticImmunomodulatingDrugIndicator",
					"Description": "Antineoplastics are drugs that inhibit and combat the development of neoplasms.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "AntineoplasticImmunomodulatingDrugIndicator"
					},
					"OriginDataTypeName": {
						"TypeName": "boolean",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "boolean"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "DrugTypeId",
					"Description": "The unique identifier of a Drug type.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "DrugTypeId"
					},
					"OriginDataTypeName": {
						"TypeName": "integer",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "integer"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "DoseFormId",
					"Description": "The unique identifier of a drug dose form.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "DoseFormId"
					},
					"OriginDataTypeName": {
						"TypeName": "integer",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "integer"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "AdministrationRouteId",
					"Description": "The unique identifier of the route, means or method of administering the associated drug/pharmaceutical product.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "AdministrationRouteId"
					},
					"OriginDataTypeName": {
						"TypeName": "integer",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "integer"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "PackageTypeId",
					"Description": "The unique identifier of a Package Type.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "PackageTypeId"
					},
					"OriginDataTypeName": {
						"TypeName": "integer",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "integer"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "ControlledSubstanceClassId",
					"Description": "The unique identifier of a Controlled Substance Class.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "ControlledSubstanceClassId"
					},
					"OriginDataTypeName": {
						"TypeName": "integer",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "integer"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "MarketingStatusId",
					"Description": "The unique identifier of a drug Marketing Status.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "MarketingStatusId"
					},
					"OriginDataTypeName": {
						"TypeName": "integer",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "integer"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "AbsorptionMethodId",
					"Description": "The unique identifier of an Absorption Method.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "AbsorptionMethodId"
					},
					"OriginDataTypeName": {
						"TypeName": "integer",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "integer"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "BiotransformationPhaseId",
					"Description": "The unique identifier of a Biotransformation Phase.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "BiotransformationPhaseId"
					},
					"OriginDataTypeName": {
						"TypeName": "integer",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "integer"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "ExcretionMethodId",
					"Description": "The unique identifier of an Excretion Method.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "ExcretionMethodId"
					},
					"OriginDataTypeName": {
						"TypeName": "integer",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "integer"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "DrugClassId",
					"Description": "The unique identifier of a Drug Class.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "DrugClassId"
					},
					"OriginDataTypeName": {
						"TypeName": "integer",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "integer"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "PregnancyCategoryId",
					"Description": "The unique identifier of a Pregnancy Category.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "PregnancyCategoryId"
					},
					"OriginDataTypeName": {
						"TypeName": "integer",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "integer"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "UscId",
					"Description": "The unique identifier of the USC.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "UscId"
					},
					"OriginDataTypeName": {
						"TypeName": "integer",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "integer"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "DrugReleaseTypeId",
					"Description": "The unique identifier of a Drug Release Type.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "DrugReleaseTypeId"
					},
					"OriginDataTypeName": {
						"TypeName": "integer",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "integer"
						}
					},
					"DeltaFormatInvalidMessages": []
				},
				{
					"Name": "DrugCategoryId",
					"Description": "The unique identifier of a Drug Category.",
					"BaseAttributeReference": {
						"Entity": "Drug.cdm.json/Drug",
						"Name": "DrugCategoryId"
					},
					"OriginDataTypeName": {
						"TypeName": "integer",
						"IsComplexType": false,
						"IsNullable": true,
						"Properties": {
							"HIVE_TYPE_STRING": "integer"
						}
					},
					"DeltaFormatInvalidMessages": []
				}
			],
			"Format": {
				"InputFormat": "org.apache.hadoop.mapred.SequenceFileInputFormat",
				"OutputFormat": "org.apache.hadoop.hive.ql.io.HiveSequenceFileOutputFormat",
				"FormatType": "csv",
				"SerializeLib": "org.apache.hadoop.hive.serde2.lazy.LazySimpleSerDe",
				"Properties": {
					"path": "abfss://llmdataraw@tpearson1256.dfs.core.windows.net/Genomics_cxj/Drug",
					"delimiter": ",",
					"multiLine": "false",
					"firstRowAsHeader": "false",
					"serialization.format": "1",
					"escape": "\\",
					"quote": "\"",
					"FormatTypeSetToDatabaseDefault": true,
					"header": "false"
				}
			},
			"Source": {
				"Provider": "ADLS",
				"Location": "abfss://llmdataraw@tpearson1256.dfs.core.windows.net/Genomics_cxj/Drug",
				"Properties": {
					"LinkedServiceName": "myadfasas-WorkspaceDefaultStorage",
					"LocationSetToDatabaseDefault": true
				}
			},
			"Properties": {
				"textinputformat.record.delimiter": ",",
				"compression": "{\"type\":\"None\",\"level\":\"optimal\"}",
				"derivedModelAttributeInfo": "{\"attributeReferences\":{\"DrugId\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"DrugId\"},\"DrugName\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"DrugName\"},\"NdcNumber\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"NdcNumber\"},\"PseudoNdcNumber\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"PseudoNdcNumber\"},\"WhodrugVersionId\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"WhodrugVersionId\"},\"WhodrugCode\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"WhodrugCode\"},\"RxnormRxcui\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"RxnormRxcui\"},\"RxnormRxaui\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"RxnormRxaui\"},\"SnomedCtConceptId\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"SnomedCtConceptId\"},\"UmlsCui\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"UmlsCui\"},\"NdfNui\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"NdfNui\"},\"DrugIdentificationNumber\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"DrugIdentificationNumber\"},\"ProductCodeName\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"ProductCodeName\"},\"DrugImprintCode\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"DrugImprintCode\"},\"DrugCodeName\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"DrugCodeName\"},\"ProductStrength\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"ProductStrength\"},\"ProductSize\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"ProductSize\"},\"DrugHalflifeDays\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"DrugHalflifeDays\"},\"FirstDateManufactured\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"FirstDateManufactured\"},\"ApprovalLetterDate\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"ApprovalLetterDate\"},\"AndaNewDrugApplicationNumber\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"AndaNewDrugApplicationNumber\"},\"BiologicLicenseApplication\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"BiologicLicenseApplication\"},\"MechanismOfActionStatement\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"MechanismOfActionStatement\"},\"InteractionsStatement\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"InteractionsStatement\"},\"PharmaceuticalDrugInteractionsStatement\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"PharmaceuticalDrugInteractionsStatement\"},\"OverdoseSymptomsStatement\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"OverdoseSymptomsStatement\"},\"OverdoseActionStatement\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"OverdoseActionStatement\"},\"DrugAntidoteDosageStatement\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"DrugAntidoteDosageStatement\"},\"DrugAntidoteStatement\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"DrugAntidoteStatement\"},\"DrugAntidoteComments\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"DrugAntidoteComments\"},\"DrugAdverseReactionsStatement\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"DrugAdverseReactionsStatement\"},\"BiologicProductIndicator\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"BiologicProductIndicator\"},\"PharmaceuticalUsageStatement\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"PharmaceuticalUsageStatement\"},\"PharmaceuticalWarningsStatement\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"PharmaceuticalWarningsStatement\"},\"PharmaceuticalPrecautionsStatement\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"PharmaceuticalPrecautionsStatement\"},\"PharmaceuticalInformationForPatientsStatement\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"PharmaceuticalInformationForPatientsStatement\"},\"PharmaceuticalPregnancyStatement\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"PharmaceuticalPregnancyStatement\"},\"PharmaceuticalNursingMothersStatement\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"PharmaceuticalNursingMothersStatement\"},\"PharmaceuticalPediatricUseStatement\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"PharmaceuticalPediatricUseStatement\"},\"PharmaceuticalDermatologicReactionsStatement\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"PharmaceuticalDermatologicReactionsStatement\"},\"PharmaceuticalHematologicReactionsStatement\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"PharmaceuticalHematologicReactionsStatement\"},\"PharmaceuticalMetabolicReactionsStatement\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"PharmaceuticalMetabolicReactionsStatement\"},\"PharmaceuticalOtherReactionsStatement\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"PharmaceuticalOtherReactionsStatement\"},\"PharmaceuticalOverdosageStatement\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"PharmaceuticalOverdosageStatement\"},\"PharmaceuticalClinicalPharmacologyStatement\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"PharmaceuticalClinicalPharmacologyStatement\"},\"PharmaceuticalIndicationsAndUsageStatement\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"PharmaceuticalIndicationsAndUsageStatement\"},\"PharmaceuticalContraindicationsStatement\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"PharmaceuticalContraindicationsStatement\"},\"PharmaceuticalLaboratoryTestsStatement\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"PharmaceuticalLaboratoryTestsStatement\"},\"PharmaceuticalCarcinogenesisStatement\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"PharmaceuticalCarcinogenesisStatement\"},\"PharmaceuticalPregnancyUsageStatement\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"PharmaceuticalPregnancyUsageStatement\"},\"PharmaceuticalPediatricUsageStatement\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"PharmaceuticalPediatricUsageStatement\"},\"PharmaceuticalAdverseReactionsStatement\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"PharmaceuticalAdverseReactionsStatement\"},\"PharmaceuticalDrugDosageAndAdministrationStatement\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"PharmaceuticalDrugDosageAndAdministrationStatement\"},\"PharmaceuticalHowSuppliedStatement\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"PharmaceuticalHowSuppliedStatement\"},\"DrugEfficacyStatement\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"DrugEfficacyStatement\"},\"ReferencedListedDrugIndicator\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"ReferencedListedDrugIndicator\"},\"EligibleForExportIndicator\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"EligibleForExportIndicator\"},\"DiscontinuedDrugIndicator\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"DiscontinuedDrugIndicator\"},\"OrphanDrugIndicator\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"OrphanDrugIndicator\"},\"InvestigationalNewDrugIndicator\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"InvestigationalNewDrugIndicator\"},\"ExperimentalDrugIndicator\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"ExperimentalDrugIndicator\"},\"ExpandedAccessDrugIndicator\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"ExpandedAccessDrugIndicator\"},\"FastTrackDrugIndicator\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"FastTrackDrugIndicator\"},\"DrugOffLabelUseDrugIndicator\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"DrugOffLabelUseDrugIndicator\"},\"GenericProductIndicator\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"GenericProductIndicator\"},\"BrandNameDrugIndicator\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"BrandNameDrugIndicator\"},\"GenericDrugIndicator\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"GenericDrugIndicator\"},\"PreferredBrandDrugIndicator\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"PreferredBrandDrugIndicator\"},\"NonPreferredBrandDrugIndicator\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"NonPreferredBrandDrugIndicator\"},\"SpecialtyDrugIndicator\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"SpecialtyDrugIndicator\"},\"OverTheCounterMedicationIndicator\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"OverTheCounterMedicationIndicator\"},\"HabitFormingDrugIndicator\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"HabitFormingDrugIndicator\"},\"PrescriptionNeededIndicator\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"PrescriptionNeededIndicator\"},\"AvailableAsGenericDrugIndicator\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"AvailableAsGenericDrugIndicator\"},\"NaturalSourcedDrugIndicator\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"NaturalSourcedDrugIndicator\"},\"SyntheticDrugIndicator\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"SyntheticDrugIndicator\"},\"TherapeuticAlternativeDrugIndicator\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"TherapeuticAlternativeDrugIndicator\"},\"SugarFreeProductIndicator\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"SugarFreeProductIndicator\"},\"AlcoholFreeProductIndicator\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"AlcoholFreeProductIndicator\"},\"SulfiteContainingProductIndicator\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"SulfiteContainingProductIndicator\"},\"DrugMayCausePhotosensitivityIndicator\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"DrugMayCausePhotosensitivityIndicator\"},\"ControlledSubstanceIndicator\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"ControlledSubstanceIndicator\"},\"RequiresPrescriptionIndicator\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"RequiresPrescriptionIndicator\"},\"ControlledReleaseProductIndicator\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"ControlledReleaseProductIndicator\"},\"ControlledDiffusionExtendedReleaseProductIndicator\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"ControlledDiffusionExtendedReleaseProductIndicator\"},\"ControlledDissolutionReleaseProductIndicator\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"ControlledDissolutionReleaseProductIndicator\"},\"OsmoticPressureSustainedReleaseProductIndicator\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"OsmoticPressureSustainedReleaseProductIndicator\"},\"DelayedReleaseProductIndicator\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"DelayedReleaseProductIndicator\"},\"DoNotCrushProductIndicator\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"DoNotCrushProductIndicator\"},\"SelfAdministeredDrugIndicator\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"SelfAdministeredDrugIndicator\"},\"EntericCoatedProductIndicator\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"EntericCoatedProductIndicator\"},\"SlowReleaseProductIndicator\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"SlowReleaseProductIndicator\"},\"TimedReleaseProductIndicator\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"TimedReleaseProductIndicator\"},\"EssentialDrugProductIndicator\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"EssentialDrugProductIndicator\"},\"FinishedProductIndicator\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"FinishedProductIndicator\"},\"PharmaceuticalProductIndicator\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"PharmaceuticalProductIndicator\"},\"LactoseFreeProductIndicator\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"LactoseFreeProductIndicator\"},\"AgonistDrugIndicator\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"AgonistDrugIndicator\"},\"AntagonistDrugIndicator\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"AntagonistDrugIndicator\"},\"GalactoseFreeProductIndicator\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"GalactoseFreeProductIndicator\"},\"CholinergicReceptorAgonistDrugIndicator\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"CholinergicReceptorAgonistDrugIndicator\"},\"CholinergicReceptorAntagonistDrugIndicator\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"CholinergicReceptorAntagonistDrugIndicator\"},\"AdrenergicReceptorAgonistDrugIndicator\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"AdrenergicReceptorAgonistDrugIndicator\"},\"AdrenergicReceptorAntagonistDrugIndicator\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"AdrenergicReceptorAntagonistDrugIndicator\"},\"AntihypertensiveDrugIndicator\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"AntihypertensiveDrugIndicator\"},\"DiureticDrugIndicator\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"DiureticDrugIndicator\"},\"AntianginalDrugIndicator\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"AntianginalDrugIndicator\"},\"AntiarrhythmicDrugIndicator\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"AntiarrhythmicDrugIndicator\"},\"HyperlipidemiaDrugIndicator\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"HyperlipidemiaDrugIndicator\"},\"HematopoieticDrugIndicator\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"HematopoieticDrugIndicator\"},\"AnticoagulantDrugIndicator\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"AnticoagulantDrugIndicator\"},\"AntiplateletDrugIndicator\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"AntiplateletDrugIndicator\"},\"FibrinolyticDrugIndicator\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"FibrinolyticDrugIndicator\"},\"SedativeHypnoticAnxiolyticDrugIndicator\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"SedativeHypnoticAnxiolyticDrugIndicator\"},\"AntiepilepticDrugIndicator\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"AntiepilepticDrugIndicator\"},\"NeurodegenerativeDrugIndicator\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"NeurodegenerativeDrugIndicator\"},\"PsychotherapeuticDrugIndicator\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"PsychotherapeuticDrugIndicator\"},\"OpioidAnalgesicDrugIndicator\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"OpioidAnalgesicDrugIndicator\"},\"LocalAnestheticDrugsIndicator\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"LocalAnestheticDrugsIndicator\"},\"GeneralAnestheticDrugsIndicator\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"GeneralAnestheticDrugsIndicator\"},\"RespiratoryTractDisorderDrugIndicator\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"RespiratoryTractDisorderDrugIndicator\"},\"GastrointestinalTractDisorderDrugIndicator\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"GastrointestinalTractDisorderDrugIndicator\"},\"HeadacheDisorderDrugIndicator\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"HeadacheDisorderDrugIndicator\"},\"PainInflammationDrugIndicator\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"PainInflammationDrugIndicator\"},\"ArthriticDisorderDrugIndicator\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"ArthriticDisorderDrugIndicator\"},\"HypothalamicPituitaryDrugIndicator\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"HypothalamicPituitaryDrugIndicator\"},\"ThyroidDrugIndicator\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"ThyroidDrugIndicator\"},\"AdrenalSteroidDrugIndicator\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"AdrenalSteroidDrugIndicator\"},\"FertilityReproductionDrugIndicator\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"FertilityReproductionDrugIndicator\"},\"DiabetesMellitusDrugIndicator\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"DiabetesMellitusDrugIndicator\"},\"CalciumAndBoneDrugIndicator\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"CalciumAndBoneDrugIndicator\"},\"AntimycobacterialDrugIndicator\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"AntimycobacterialDrugIndicator\"},\"AntibacterialDrugIndicator\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"AntibacterialDrugIndicator\"},\"AntifungalDrugIndicator\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"AntifungalDrugIndicator\"},\"AntiviralDrugIndicator\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"AntiviralDrugIndicator\"},\"AntiparasiticDrugIndicator\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"AntiparasiticDrugIndicator\"},\"AntineoplasticImmunomodulatingDrugIndicator\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"AntineoplasticImmunomodulatingDrugIndicator\"},\"DrugTypeId\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"DrugTypeId\"},\"DoseFormId\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"DoseFormId\"},\"AdministrationRouteId\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"AdministrationRouteId\"},\"PackageTypeId\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"PackageTypeId\"},\"ControlledSubstanceClassId\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"ControlledSubstanceClassId\"},\"MarketingStatusId\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"MarketingStatusId\"},\"AbsorptionMethodId\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"AbsorptionMethodId\"},\"BiotransformationPhaseId\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"BiotransformationPhaseId\"},\"ExcretionMethodId\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"ExcretionMethodId\"},\"DrugClassId\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"DrugClassId\"},\"PregnancyCategoryId\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"PregnancyCategoryId\"},\"UscId\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"UscId\"},\"DrugReleaseTypeId\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"DrugReleaseTypeId\"},\"DrugCategoryId\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"DrugCategoryId\"}}}"
			},
			"Compressed": false,
			"IsStoredAsSubdirectories": false
		},
		"Properties": {
			"DerivedModelEntityInfo": "{\"entityDirectives\":{\"baseEntityReference\":{\"name\":\"Drug\",\"path\":\"Drug.cdm.json/Drug\"},\"description\":\"A Pharmaceutical 'product' is a product that has undergone all stages of production, including packaging in its final container and labeling.  It is a good or item capable of satisfying a need or a want that is offered to a target market for attention, acquisition, use or consumption.      \\n\\nThe finished dosage form that contains a drug substance, generally, but not necessarily in association with other active or inactive ingredients. \\n\\nA drug is defined as: \\n- A substance recognized by an official pharmacopoeia or formulary. \\n\\n- A substance intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease. \\n\\n- A substance (other than food) intended to affect the structure or any function of the body. \\n\\n- A substance intended for use as a component of a medicine but not a device or a component, part or accessory of a device. \\n\\nA product number is assigned to each drug product associated with an NDA (New Drug Application).  If a drug product is available in multiple strengths, there are multiple product numbers.\\n\\nBiologic products are included within this definition and are generally covered by the same laws and regulations, but differences exist regarding their manufacturing processes (chemical process vs. biological process.) \\n\\nA finished dosage form (e.g. tablet, capsule, or solution) that contains the active drug ingredient usually combined with inactive ingredients.\\n\\nEach product has its own benefits, quality, brand name, and packaging that gives it its own identity and distinguishing characteristics.  \\n\\nEvery business or organization has business rules that define precisely what a product is.    While we intuitively know what a product is, we must quantify that knowledge and associated business rules so that consistent applications can be developed.\\n\\nA product typically goes through five stages of development:\\n\\n(1)  Idea Stage - involving a thorough evaluation of the potential product\\n\\n(2)  Concept Stage - determines customer acceptance by testing and presentation to consumers and distribution channel members.   Specific aspects regarding quality, dependability, reliability, warranty, packaging, service, pricing, terms of sale, sales and distribution channels, advertising and promotions are evaluated.\\n\\n(3)  Product Development Stage - transforms the prototype product into an actual product for mass sale.   This stage requires close interaction between both marketing and manufacturing.\\n\\n(4)  Test Marketing Stage - may or may not be used since it is an expensive and time-consuming process.  Test marketing involves evaluating various product options and alternatives.\\n\\n(5)  Commercialization - It is very expensive to launch a new product so commercialization only applies to those specific products that are actually going to be sold to the market.\",\"primaryKey\":[\"DrugId\"],\"projectionInfo\":{\"attributes\":[{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"DrugId\"},\"dataType\":\"long\",\"description\":\"The unique identifier of a drug.\",\"isNullable\":false,\"name\":\"DrugId\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"DrugName\"},\"dataType\":\"string\",\"dataTypeLength\":128,\"description\":\"The name of the pharmaceutical product, which normally corresponds to the 'marketing name' of the Product.\",\"isNullable\":true,\"name\":\"DrugName\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"NdcNumber\"},\"dataType\":\"decimal\",\"dataTypeLength\":10,\"description\":\"Identification of reportable controlled substances is always based on the Food and Drug Administration's National Drug Code (NDC). The National Drug Code (NDC) used by ARCOS is an 11-character code that identifies controlled substance products.\\n\\nThe NDC System was originally established as an essential part of an out-of-hospital drug reimbursement program under Medicare. The NDC serves as a universal product identifier for human drugs. \\n\\nThe Drug Listing Act of 1972, amending the Federal Food, Drug, and Cosmetic Act, became effective February 1, 1973. Its purpose is to provide the Commissioner of the Food and Drug Administration (FDA) a current list of all drugs manufactured, prepared, propagated, compounded, or processed by a drug establishment registered under the Federal Food, Drug, and Cosmetic Act. The act requires submission of information on commercially marketed drugs and is used in the enforcement of the Federal Food, Drug, and Cosmetic Act.\",\"isNullable\":true,\"scale\":0,\"name\":\"NdcNumber\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"PseudoNdcNumber\"},\"dataType\":\"decimal\",\"dataTypeLength\":10,\"description\":\"A code developed by DEA (ARCOS) in consultation with the ARCOS registrant which enables ARCOS registrants to report transactions involving products for which an NDC does not exist.\",\"isNullable\":true,\"scale\":0,\"name\":\"PseudoNdcNumber\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"WhodrugVersionId\"},\"dataType\":\"integer\",\"description\":\"The unique identifier of a WHODrug Version.\",\"isNullable\":true,\"name\":\"WhodrugVersionId\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"WhodrugCode\"},\"dataType\":\"integer\",\"description\":\"The unique identifier of a WHODrug consists of a an 11-digit code.\",\"isNullable\":true,\"name\":\"WhodrugCode\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"RxnormRxcui\"},\"dataType\":\"string\",\"dataTypeLength\":1024,\"description\":\"RxNorm Unique identifier for concept (concept ID)\",\"isNullable\":true,\"name\":\"RxnormRxcui\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"RxnormRxaui\"},\"dataType\":\"string\",\"dataTypeLength\":1024,\"description\":\"Unique identifier for atom (RxNorm Atom ID)\",\"isNullable\":true,\"name\":\"RxnormRxaui\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"SnomedCtConceptId\"},\"dataType\":\"integer\",\"description\":\"The unique identifier of a SNOMED CT Concept.\",\"isNullable\":true,\"name\":\"SnomedCtConceptId\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"UmlsCui\"},\"dataType\":\"string\",\"dataTypeLength\":1024,\"description\":\"A unique identifier assigned in UMLS for a drug concept.\",\"isNullable\":true,\"name\":\"UmlsCui\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"NdfNui\"},\"dataType\":\"string\",\"dataTypeLength\":1024,\"description\":\"A unique identifier assigned in NDF-RT for every drug concept.\",\"isNullable\":true,\"name\":\"NdfNui\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"DrugIdentificationNumber\"},\"dataType\":\"integer\",\"description\":\"A Drug Identification Number (DIN) is a computer-generated eight digit number assigned by Health Canada to a drug product prior to being marketed in Canada. It uniquely identifies all drug products sold in a dosage form in Canada and is located on the label of prescription and over-the-counter drug products that have been evaluated and authorized for sale in Canada.\",\"isNullable\":true,\"name\":\"DrugIdentificationNumber\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"ProductCodeName\"},\"dataType\":\"string\",\"dataTypeLength\":128,\"description\":\"The internal code name by which the pharmaceutical product is known within the company.\",\"isNullable\":true,\"name\":\"ProductCodeName\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"DrugImprintCode\"},\"dataType\":\"binary\",\"description\":\"Imprint Code any single letter or number or any combination of letter(s) and numbers assigned by a drug firm to a specific drug product.\",\"isNullable\":true,\"name\":\"DrugImprintCode\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"DrugCodeName\"},\"dataType\":\"string\",\"dataTypeLength\":128,\"description\":\"The internal code name by which the pharmaceutical product is known within the company.\",\"isNullable\":true,\"name\":\"DrugCodeName\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"ProductStrength\"},\"dataType\":\"decimal\",\"dataTypeLength\":18,\"description\":\"The pharmaceutical product strength.\\n\\nEx:\\n\\nProduct Name = Pindolol\\nProduct Strength = Tablets USP 5mg\",\"isNullable\":true,\"scale\":2,\"name\":\"ProductStrength\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"ProductSize\"},\"dataType\":\"decimal\",\"dataTypeLength\":18,\"description\":\"The size of the associated pharmaceutical product.\\n\\nEx:\\n\\nProduct = Adalat\\nProduct Number = 88110\\nNational Drug Code Number = 0028-8811-51\\nSize = Bottle - 100's\\nSuggested Price To Retailer = $46.51\",\"isNullable\":true,\"scale\":2,\"name\":\"ProductSize\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"DrugHalflifeDays\"},\"dataType\":\"integer\",\"description\":\"Amount of time needed for half of the amount of drug administered to be eliminated from the body.\",\"isNullable\":true,\"name\":\"DrugHalflifeDays\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"FirstDateManufactured\"},\"dataType\":\"date\",\"dateFormat\":\"YYYY-MM-DD\",\"description\":\"The date that the Product was first manufactured by the Manufacturer.\",\"isNullable\":true,\"name\":\"FirstDateManufactured\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"ApprovalLetterDate\"},\"dataType\":\"date\",\"dateFormat\":\"YYYY-MM-DD\",\"description\":\"An official communication from FDA to a new drug application (NDA) sponsor that allows the commercial marketing of the product.\",\"isNullable\":true,\"name\":\"ApprovalLetterDate\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"AndaNewDrugApplicationNumber\"},\"dataType\":\"integer\",\"description\":\"This six digit number is assigned by FDA staff to each application for approval to market a generic drug in the United States.\\n\\nAbbreviated New Drug Application (ANDA) simplified submission permitted for a duplicate of an already approved drug. ANDAs are for products with the same or very closely related active ingredients, dose form, strength, administration route, use, and labeling as a product that has already been shown to be safe and effective. \\n\\nWhen the patent and marketing exclusivity for a particular drug has expired, the drug may be manufactured by other companies as well. Manufacturers of these generic or \\\"me-too\\\" forms are not required to repeat the extensive preclinical and clinical testing required for new drugs. Rather, they may submit an Abbreviated New Drug Application (ANDA) documenting the bioequivalence of their formulation of the drug. The FDA reviews ANDAs to compare the generic product to the original product to ensure that comparable blood levels of active ingredients are produced. \\n\\nAn Abbreviated New Drug Application (ANDA) contains data that, when submitted to FDA's Center for Drug Evaluation and Research, Office of Generic Drugs, provides for the review and ultimate approval of a generic drug product. Generic drug applications are called \\\"abbreviated\\\" because they are generally not required to include preclinical (animal) and clinical (human) data to establish safety and effectiveness.  Instead, a generic applicant must scientifically demonstrate that its product is bioequivalent (i.e., performs in the same manner as the innovator drug). Once approved, an applicant may manufacture and market the generic drug product to provide a safe, effective, low cost alternative to the American public.\",\"isNullable\":true,\"name\":\"AndaNewDrugApplicationNumber\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"BiologicLicenseApplication\"},\"dataType\":\"integer\",\"description\":\"Biological products are approved for marketing under the provisions of the Public Health Service (PHS) Act. The Act requires a firm who manufactures a biologic for sale in interstate commerce to hold a license for the product. A biologics license application is a submission that contains specific information on the manufacturing processes, chemistry, pharmacology, clinical pharmacology and the medical affects of the biologic product. If the information provided meets FDA requirements, the application is approved and a license is issued allowing the firm to market the product.\",\"isNullable\":true,\"name\":\"BiologicLicenseApplication\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"MechanismOfActionStatement\"},\"dataType\":\"string\",\"dataTypeLength\":2048,\"description\":\"A statement describing how a drug achieves its therapeutic effects at the cellular, tissue and organ levels as appropriate.\",\"isNullable\":true,\"name\":\"MechanismOfActionStatement\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"InteractionsStatement\"},\"dataType\":\"string\",\"dataTypeLength\":2048,\"description\":\"A statement describing drugs, foods or activities that can cause important, problematic or life-threatening interactions with the topic drug.\",\"isNullable\":true,\"name\":\"InteractionsStatement\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"PharmaceuticalDrugInteractionsStatement\"},\"dataType\":\"string\",\"dataTypeLength\":2048,\"description\":\"The drug interactions statement associated with the pharmaceutical product.\",\"isNullable\":true,\"name\":\"PharmaceuticalDrugInteractionsStatement\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"OverdoseSymptomsStatement\"},\"dataType\":\"string\",\"dataTypeLength\":2048,\"description\":\"The symptoms associated with drug overdose.\",\"isNullable\":true,\"name\":\"OverdoseSymptomsStatement\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"OverdoseActionStatement\"},\"dataType\":\"string\",\"dataTypeLength\":2048,\"description\":\"A statement regarding what to do in case of an overdose.\",\"isNullable\":true,\"name\":\"OverdoseActionStatement\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"DrugAntidoteDosageStatement\"},\"dataType\":\"string\",\"dataTypeLength\":2048,\"description\":\"A statement describing the one or more drug product antidotes dosage.\\n\\nEx:\\n\\nDrug = ISONIAZID\\n\\nAntidote = Pyridoxine\\n\\nDosage = Pyridoxine IV in the amount of INH ingested or 5gm if amount is unknown, given over 30-60 minutes.\\n\\nComments = Cumulative dose of pyridoxine is arbitrarily limited to 40gm in adults and 20gm in children.\",\"isNullable\":true,\"name\":\"DrugAntidoteDosageStatement\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"DrugAntidoteStatement\"},\"dataType\":\"string\",\"dataTypeLength\":2048,\"description\":\"A statement describing the one or more drug product antidotes.\\n\\nEx:\\n\\nDrug = ISONIAZID\\n\\nAntidote = Pyridoxine\\n\\nDosage = Pyridoxine IV in the amount of INH ingested or 5gm if amount is unknown, given over 30-60 minutes.\\n\\nComments = Cumulative dose of pyridoxine is arbitrarily limited to 40gm in adults and 20gm in children.\",\"isNullable\":true,\"name\":\"DrugAntidoteStatement\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"DrugAntidoteComments\"},\"dataType\":\"string\",\"dataTypeLength\":1024,\"description\":\"Comments regarding the one or more drug product antidotes dosage.\\n\\nEx:\\n\\nDrug = ISONIAZID\\n\\nAntidote = Pyridoxine\\n\\nDosage = Pyridoxine IV in the amount of INH ingested or 5gm if amount is unknown, given over 30-60 minutes.\\n\\nComments = Cumulative dose of pyridoxine is arbitrarily limited to 40gm in adults and 20gm in children.\",\"isNullable\":true,\"name\":\"DrugAntidoteComments\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"DrugAdverseReactionsStatement\"},\"dataType\":\"string\",\"dataTypeLength\":2048,\"description\":\"The approval letter statement regarding adverse reactions.\\n\\nEx:\\n\\nThe most commonly reported side effect of methoxsalen alone is nausea, which occurs with approximately 10% of all patients. This effect may be minimized or avoided by instructing the patient to take methoxsalen with milk or food, or to divide the dose into two portions, taken approximately one-half hour apart. Other effects include nervousness, insomnia, and psychological depression.\",\"isNullable\":true,\"name\":\"DrugAdverseReactionsStatement\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"BiologicProductIndicator\"},\"dataType\":\"boolean\",\"description\":\"A biologic product is any virus, serum, toxin, antitoxin, vaccine, blood, blood component or derivative, allergenic product, or analogous product applicable to the prevention, treatment, or cure of diseases or injuries.  Biologic products are a subset of \\\"drug products\\\" distinguished by their manufacturing processes (biological process vs. chemical process). In general, the term \\\"drugs\\\" includes biologic products.\",\"isNullable\":true,\"name\":\"BiologicProductIndicator\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"PharmaceuticalUsageStatement\"},\"dataType\":\"string\",\"dataTypeLength\":2048,\"description\":\"A medication guide contains information for patients' understanding of how to safely use a drug product.\",\"isNullable\":true,\"name\":\"PharmaceuticalUsageStatement\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"PharmaceuticalWarningsStatement\"},\"dataType\":\"string\",\"dataTypeLength\":2048,\"description\":\"The warming statement associated with the pharmaceutical product.\\n\\nEx:\\n\\nWARNINGS - GENERAL\\nA. SKIN BURNING: Serious burns from either UVA or sunlight (even through window glass) can result if the recommended dosage of the drug and/or exposure schedules are not maintained.\\n\\nB. CARCINOGENICITY:\\n1. ANIMAL STUDIES: Topical or intraperitoneal methoxsalen has been reported to be a potent photocarcinogen in albino mice and hairless mice. However, methoxsalen given by the oral route to albino mice or by any route in pigmented mice is considerably less phototoxic or carcinogenic (Hakim et al. 196011, Pathak et al. 195912).\\n2. HUMAN STUDIES: A prospective study of 1380 patients over 5 years revealed an approximately nine-fold increase in risks of squamous cell carcinoma among PUVA treated patients (Stern et al. 197913 and Stern et al. 198014). This increase in risk appears greatest among patients who are fair skinned or had pre-PUVA exposure to 1) prolonged tar and UVB treatment, 2) ionizing radiation, or 3) arsenic.\\n\\nIn addition, an approximately two-fold increase in the risk of basal cell carcinoma was noted in this study. Roenigk et al. 198015 studied 690 patients for up to 4 years and found no increase in the risk of non-melanoma skin cancer. However, patients in this cohort had significantly less exposure to PUVA than in the Stern et al study. Recent analysis of new data in the Stern et al.cohort (Stern et al., 199716) has shown that these patients had an elevated risk of contracting melanoma. The relative risk for melanoma in these patients was 2.3 (95 percent confidence interval 1.1 to 4.1). The risk is particularly higher in those patients who have received more than 250 PUVA treatments and in those whose treatment has spanned greater than 15 years. Some patients developing melanoma did so even after having ceased PUVA therapy over 5 years earlier. These observations indicate the need for monitoring of PUVA patients for skin tumors throughout their lives.\\n\\nIn a study in Indian patients treated for 4 years for vitiligo, 12 percent developed keratoses, but not cancer, in the depigmented, vitiliginous areas (Mosher,198017). Clinically, the keratoses were keratotic papules, actinic keratosis-like macules, nonscaling dome-shaped papules, and lichenoid porokeratotic-like papules.\",\"isNullable\":true,\"name\":\"PharmaceuticalWarningsStatement\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"PharmaceuticalPrecautionsStatement\"},\"dataType\":\"string\",\"dataTypeLength\":2048,\"description\":\"The precautions statement associated with the pharmaceutical product.\",\"isNullable\":true,\"name\":\"PharmaceuticalPrecautionsStatement\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"PharmaceuticalInformationForPatientsStatement\"},\"dataType\":\"string\",\"dataTypeLength\":2048,\"description\":\"The information for patients statement associated with the pharmaceutical product.\",\"isNullable\":true,\"name\":\"PharmaceuticalInformationForPatientsStatement\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"PharmaceuticalPregnancyStatement\"},\"dataType\":\"string\",\"dataTypeLength\":2048,\"description\":\"The warming statement regarding pregnant patients associated with the pharmaceutical product.\",\"isNullable\":true,\"name\":\"PharmaceuticalPregnancyStatement\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"PharmaceuticalNursingMothersStatement\"},\"dataType\":\"string\",\"dataTypeLength\":2048,\"description\":\"The warming statement regarding pregnant and nursing mother patients associated with the pharmaceutical product.\\n\\nEx:\\n\\nNURSING MOTHERS: It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when methoxsalen is administered to a nursing woman.\",\"isNullable\":true,\"name\":\"PharmaceuticalNursingMothersStatement\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"PharmaceuticalPediatricUseStatement\"},\"dataType\":\"string\",\"dataTypeLength\":2048,\"description\":\"The warming statement regarding pediatric patients associated with the pharmaceutical product.\",\"isNullable\":true,\"name\":\"PharmaceuticalPediatricUseStatement\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"PharmaceuticalDermatologicReactionsStatement\"},\"dataType\":\"string\",\"dataTypeLength\":2048,\"description\":\"The dermatologic reactions warming statement associated with the pharmaceutical product.\",\"isNullable\":true,\"name\":\"PharmaceuticalDermatologicReactionsStatement\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"PharmaceuticalHematologicReactionsStatement\"},\"dataType\":\"string\",\"dataTypeLength\":2048,\"description\":\"The hematologic reactions warming statement associated with the pharmaceutical product.\",\"isNullable\":true,\"name\":\"PharmaceuticalHematologicReactionsStatement\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"PharmaceuticalMetabolicReactionsStatement\"},\"dataType\":\"string\",\"dataTypeLength\":2048,\"description\":\"The metabolic reactions warming statement associated with the pharmaceutical product.\",\"isNullable\":true,\"name\":\"PharmaceuticalMetabolicReactionsStatement\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"PharmaceuticalOtherReactionsStatement\"},\"dataType\":\"string\",\"dataTypeLength\":2048,\"description\":\"The other reactions warming statement associated with the pharmaceutical product.\",\"isNullable\":true,\"name\":\"PharmaceuticalOtherReactionsStatement\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"PharmaceuticalOverdosageStatement\"},\"dataType\":\"string\",\"dataTypeLength\":2048,\"description\":\"The overdosage warming statement associated with the pharmaceutical product.\\n\\nEx:\\n\\nIn the event of methoxsalen overdosage, induce emesis and keep the patient in a darkened room for at least 24 hours. Emesis is beneficial only within the first 2 to 3 hours after ingestion of methoxsalen, since maximum blood levels are reached by this time.\",\"isNullable\":true,\"name\":\"PharmaceuticalOverdosageStatement\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"PharmaceuticalClinicalPharmacologyStatement\"},\"dataType\":\"string\",\"dataTypeLength\":2048,\"description\":\"A statement regarding the clinical pharmacology of the drug.\\n\\nEx:\\n\\nCLINICAL PHARMACOLOGY\\nThe combination treatment regimen of psoralen (P) and ultraviolet radiation of 320-400 nm wavelength commonly referred to as UVA is known by the acronym, PUVA. Skin reactivity to UVA (320-400 nm) radiation is markedly enhanced by the ingestion of methoxsalen. The drug reaches its maximum bioavailability 1 1/2-3 hours after oral administration and may last for up to 8 hours (Pathak et al. 1974)1. Methoxsalen is reversibly bound to serum albumin and is also preferentially taken up by epidermal cells (Artuc et al. 1979)2. At a dose which is six times larger than that used in humans, it induces mixed function oxidases in the liver of mice (Mandula et al. 1978)3. In both mice and man, methoxsalen is rapidly metabolized. Approximately 95% of the drug is excreted as a series of metabolites in the urine within 24 hours (Pathak et al. 1977)4.\\nThe exact mechanism of action of methoxsalen with the epidermal melanocytes and keratinocytes is not known. The best known biochemical reaction of methoxsalen is with DNA. Methoxsalen, upon photoactivation, conjugates and forms covalent bonds with DNA which leads to the formation of both monofunctional (addition to a single strand of DNA) and bifunctional adducts (crosslinking of psoralen to both strands of DNA) (Dall'Acqua et al., 19715; Cole, 19706; Musajo et al., 19747; Dall'Acqua et al., 19798). Reactions with proteins have also been described (Yoshikawa, et al., 19799).\\nMethoxsalen acts as a photosensitizer. Administration of the drug and subsequent exposure to UVA can lead to cell injury. Orally administered methoxsalen reaches the skin via the blood and UVA penetrates well into the skin. If sufficient cell injury occurs in the skin, an inflammatory reaction occurs. The most obvious manifestation of this reaction is delayed erythema, which may not begin for several hours and peaks at 48-72 hours. The inflammation is followed, over several days to weeks, by repair which is manifested by increased melanization of the epidermis and thickening of the stratum corneum. The mechanisms of therapy are not known. In the treatment of vitiligo, it has been suggested that melanocytes in the hair follicle are stimulated to\\n \\nNDA 9-048/S-037 Page 4\\nmove up the follicle and to repopulate the epidermis (Ortonne et al, 197910). In the treatment of psoriasis, the mechanism is most often assumed to be DNA photodamage and resulting decrease in cell proliferation but other vascular, leukocyte, or cell regulatory mechanisms may also be playing some role. Psoriasis is a hyperproliferative disorder and other agents known to be therapeutic for psoriasis are known to inhibit DNA synthesis.\",\"isNullable\":true,\"name\":\"PharmaceuticalClinicalPharmacologyStatement\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"PharmaceuticalIndicationsAndUsageStatement\"},\"dataType\":\"string\",\"dataTypeLength\":2048,\"description\":\"The approval letter statement of indications and usage of the drug.\\n\\nEx:\\n\\nA. Photochemotherapy (methoxsalen with long wave UVA radiation) is indicated for the symptomatic control of severe, recalcitrant, disabling psoriasis not adequately responsive to other forms of therapy and when the diagnosis has been supported by biopsy. Photochemotherapy is intended to be administered only in conjunction with a schedule of controlled doses of long wave ultraviolet radiation.\\n\\nB. Photochemotherapy (methoxsalen with long wave ultraviolet radiation) is indicated for the repigmentation of idiopathic vitiligo.\\n\\nC. Photopheresis (methoxsalen with long wave ultraviolet radiation of white blood cells) is indicated for use with the UVAR* System in the palliative treatment of the skin manifestations of cutaneous T-cell lymphoma (CTCL) in persons who have not been responsive to other forms of treatment. While this dosage form of methoxsalen has been approved for use in combination with photopheresis, Oxsoralen Ultra~ Capsules have not been approved for that use.\",\"isNullable\":true,\"name\":\"PharmaceuticalIndicationsAndUsageStatement\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"PharmaceuticalContraindicationsStatement\"},\"dataType\":\"string\",\"dataTypeLength\":2048,\"description\":\"The drug approval letter statement regarding contraindications.\\n\\nEx:\\n\\nA.  Patients exhibiting idiosyncratic reactions to psoralen compounds.\\n\\nB.  Patients possessing a specific history of light sensitive disease states should not initiate methoxsalen therapy. Diseases associated with photosensitivity include lupus erythematosus, porphyria cutanea tarda, erythropoietic protoporphyria, variegate porphyria, xeroderma pigmentosum, and albinism.\\n\\nC.  Patients exhibiting melanoma or possessing a history of melanoma.\\n\\nD.  Patients exhibiting invasive squamous cell carcinomas.\\n\\nD.  Patients with aphakia, because of the significantly increased risk of retinal damage due to the absence of lenses.\",\"isNullable\":true,\"name\":\"PharmaceuticalContraindicationsStatement\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"PharmaceuticalLaboratoryTestsStatement\"},\"dataType\":\"string\",\"dataTypeLength\":2048,\"description\":\"The approval letter statement regarding laboratory tests.\\n\\nEx:\\n\\nC. LABORATORY TESTS:\\n1. Patients should have an ophthalmologic examination prior to start of therapy, and thence yearly.\\n3. Patients should have the following tests prior to the start of therapy and should be retested 6-12 months\\nsubsequently. Additional tests at more extended time periods should be conducted as clinically indicated.\\na. Complete Blood Count (Hemoglobin or Hematocrit; White Blood Count-if abnormal, a differential\\ncount).\\nb. Anti-nuclear Antibodies.\\nc. Liver Function Tests.\\nd. Renal Function Tests (Creatinine or Blood Urea Nitrogen).\",\"isNullable\":true,\"name\":\"PharmaceuticalLaboratoryTestsStatement\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"PharmaceuticalCarcinogenesisStatement\"},\"dataType\":\"string\",\"dataTypeLength\":2048,\"description\":\"The approval letter statement regarding carcinogenic issues.\\n\\nEx:\",\"isNullable\":true,\"name\":\"PharmaceuticalCarcinogenesisStatement\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"PharmaceuticalPregnancyUsageStatement\"},\"dataType\":\"string\",\"dataTypeLength\":2048,\"description\":\"The approval letter statement regarding usage by pregnant women.\\n\\nEx:\\n\\nPregnancy Category C. Animal reproduction studies have not been conducted with methoxsalen. It is also not known whether methoxsalen can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Methoxsalen should be given to a woman only if clearly needed.\",\"isNullable\":true,\"name\":\"PharmaceuticalPregnancyUsageStatement\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"PharmaceuticalPediatricUsageStatement\"},\"dataType\":\"string\",\"dataTypeLength\":2048,\"description\":\"The approval letter statement regarding children.\\n\\nEx:\\n\\nPEDIATRIC USE:\\nSafety in children has not been established. Potential hazards of long-term therapy include the possibilities of carcinogenicity and cataractogenicity as described in the Warnings Section as well as the probability of actinic degeneration which is also described in the Warnings Section.\",\"isNullable\":true,\"name\":\"PharmaceuticalPediatricUsageStatement\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"PharmaceuticalAdverseReactionsStatement\"},\"dataType\":\"string\",\"dataTypeLength\":2048,\"description\":\"The approval letter statement regarding adverse reactions.\\n\\nEx:\\n\\nThe most commonly reported side effect of methoxsalen alone is nausea, which occurs with approximately 10% of all patients. This effect may be minimized or avoided by instructing the patient to take methoxsalen with milk or food, or to divide the dose into two portions, taken approximately one-half hour apart. Other effects include nervousness, insomnia, and psychological depression.\",\"isNullable\":true,\"name\":\"PharmaceuticalAdverseReactionsStatement\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"PharmaceuticalDrugDosageAndAdministrationStatement\"},\"dataType\":\"string\",\"dataTypeLength\":2048,\"description\":\"The approval letter statement regarding drug usage and administration.\\n\\nEx:\\n\\nDRUG DOSAGE: Two capsules (10 mg each) in one dose taken with milk or in food two to four hours before ultraviolet light exposure.\",\"isNullable\":true,\"name\":\"PharmaceuticalDrugDosageAndAdministrationStatement\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"PharmaceuticalHowSuppliedStatement\"},\"dataType\":\"string\",\"dataTypeLength\":2048,\"description\":\"The approval letter statement regarding how the drug is supplied.\\n\\nEx:\\n\\n8-MOP Capsules, each containing 10 mg. of methoxsalen (8-methoxypsoralen) packaged in amber glass bottles of 50 (NDC 0187-0651-42).\",\"isNullable\":true,\"name\":\"PharmaceuticalHowSuppliedStatement\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"DrugEfficacyStatement\"},\"dataType\":\"string\",\"dataTypeLength\":2048,\"description\":\"A statement regarding the maximum ability of a drug or treatment to produce a result regardless of dosage. A drug passes efficacy trials if it is effective at the dose tested and against the illness for which it is prescribed. In the procedure mandated by the FDA, Phase II clinical trials gauge efficacy, and Phase III trials confirm it\",\"isNullable\":true,\"name\":\"DrugEfficacyStatement\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"ReferencedListedDrugIndicator\"},\"dataType\":\"boolean\",\"description\":\"A Reference Listed Drug is an approved drug product to which new generic versions are compared to show that they are bioequivalent. A drug company seeking approval to market a generic equivalent must refer to the Reference Listed Drug in its Abbreviated New Drug Application (ANDA).  By designating a single reference listed drug as the standard to which all generic versions must be shown to be bioequivalent, FDA hopes to avoid possible significant variations among generic drugs and their brand name counterpart.\",\"isNullable\":true,\"name\":\"ReferencedListedDrugIndicator\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"EligibleForExportIndicator\"},\"dataType\":\"boolean\",\"description\":\"Indicates that the pharmaceutical product is eligible for export to foreign countries without restriction.\",\"isNullable\":true,\"name\":\"EligibleForExportIndicator\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"DiscontinuedDrugIndicator\"},\"dataType\":\"boolean\",\"description\":\"A discontinued drug is a drug product that has been removed from the market in the United States for reasons other than safety or effectiveness.\",\"isNullable\":true,\"name\":\"DiscontinuedDrugIndicator\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"OrphanDrugIndicator\"},\"dataType\":\"boolean\",\"description\":\"An FDA category that refers to medications used to treat diseases and conditions that occur rarely. There is little financial incentive for the pharmaceutical industry to develop medications for these diseases or conditions. \\n\\nOrphan drug status, however, gives a manufacturer specific financial incentives to develop and provide such medications.\\n\\nA designation of the FDA to indicate a therapy developed to treat a rare disease (one which afflicts a U.S. population of less than 200,000 people). \\n\\nBecause there are few financial incentives for drug companies to develop therapies for diseases that afflict so few people, the U.S. government offers additional incentives to drug companies (i.e. tax advantages and extended marketing exclusivity) that develop these drugs.\",\"isNullable\":true,\"name\":\"OrphanDrugIndicator\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"InvestigationalNewDrugIndicator\"},\"dataType\":\"boolean\",\"description\":\"A new drug, antibiotic drug, or biological drug that is used in a clinical investigation. It also includes a biological product used in vitro for diagnostic purposes.\",\"isNullable\":true,\"name\":\"InvestigationalNewDrugIndicator\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"ExperimentalDrugIndicator\"},\"dataType\":\"boolean\",\"description\":\"A drug that is not FDA licensed for use in humans, or as a treatment for a particular condition\",\"isNullable\":true,\"name\":\"ExperimentalDrugIndicator\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"ExpandedAccessDrugIndicator\"},\"dataType\":\"boolean\",\"description\":\"Some investigational drugs are available from pharmaceutical manufacturers through expanded access programs.\\n\\nRefers to any of the FDA procedures, such as compassionate use, parallel track, and treatment IND that distribute experimental drugs to participants who are failing on currently available treatments for their condition and also are unable to participate in ongoing clinical trials.\\n\\nMost human use of investigational new drugs takes place in controlled clinical trials conducted to assess safety and efficacy of new drugs. \\n\\nData from the trials can serve as the basis for the drug marketing application. Sometimes, patients do not qualify for these carefully-controlled trials be cause of other health problems, age, or other factors. \\n\\nFor patients who may benefit from the drug use but don't qualify for the trials, FDA regulations enable manufacturers of investigational new drugs to provide for \\\"expanded access\\\" use of the drug. \\n\\nFor example, a treatment IND (Investigational New Drug application) or treatment protocol is a relatively unrestricted study. The primary intent of a treatment IND/protocol is to provide for access to the new drug for people with a life-threatening or serious disease for which there is no good alternative treatment. \\n\\nA secondary purpose for a treatment IND/protocol is to generate additional information about the drug, especially its safety. Expanded access protocols can be undertaken only if clinical investigators are actively studying the experimental treatment in well-controlled studies, or all studies have been completed. \\nThere must be evidence that the drug may be an effective treatment in patients like those to be treated under the protocol. \\n\\nThe drug cannot expose patients to unreasonable risks given the severity of the disease to be treated.\\n\\nExpanded access protocols are generally managed by the manufacturer, with the investigational treatment administered by researchers or doctors in office-based practice.\",\"isNullable\":true,\"name\":\"ExpandedAccessDrugIndicator\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"FastTrackDrugIndicator\"},\"dataType\":\"boolean\",\"description\":\"If the FDA determines that a drug shows promise in meeting a severe, unmet medical need, it may grant the drug's sponsor a fast track designation for the development of that drug. For most drugs, the FDA has 12 months to review marketing approval documents; the FDA must review similar materials for fast-tracked drugs within 6 months.\\n\\nThe U.S. Food and Drug Administration is a collection of government employees responsible for ensuring that foods, drugs, and cosmetics sold in the U.S. are safe for use, and, in the case of drugs, effective as well.\",\"isNullable\":true,\"name\":\"FastTrackDrugIndicator\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"DrugOffLabelUseDrugIndicator\"},\"dataType\":\"boolean\",\"description\":\"A drug prescribed for conditions other than those approved by the FDA.\",\"isNullable\":true,\"name\":\"DrugOffLabelUseDrugIndicator\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"GenericProductIndicator\"},\"dataType\":\"boolean\",\"description\":\"The term generic product has somewhat different meanings in different jurisdictions. \\n\\nUse of this term is therefore avoided as much as possible, and the term multisource pharmaceutical product  is used instead. \\n\\nGeneric products may be marketed either under the approved nonproprietary name or under a brand (proprietary) name. They may be marketed in dosage forms and/or strengths different from those of the innovator products. Where the term generic product is used, it means a pharmaceutical product, usually intended to be interchangeable with the innovator product, which is usually manufactured without a license from the innovator company and marketed after expiry of the patent or other exclusivity rights.\",\"isNullable\":true,\"name\":\"GenericProductIndicator\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"BrandNameDrugIndicator\"},\"dataType\":\"boolean\",\"description\":\"A brand name drug is a drug marketed under a proprietary, trademark-protected name.\",\"isNullable\":true,\"name\":\"BrandNameDrugIndicator\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"GenericDrugIndicator\"},\"dataType\":\"boolean\",\"description\":\"Indicates whether the drug is a generic drug.\\n\\nA non-brand name drug which has the same active ingredient, strength and dosage form, and which is determined by the FDA to be therapeutically equivalent to the drug product identified in the prescription.\",\"isNullable\":true,\"name\":\"GenericDrugIndicator\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"PreferredBrandDrugIndicator\"},\"dataType\":\"boolean\",\"description\":\"Brand name drugs that are clinically effective, cost effective and meet the needs of most patients.\",\"isNullable\":true,\"name\":\"PreferredBrandDrugIndicator\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"NonPreferredBrandDrugIndicator\"},\"dataType\":\"boolean\",\"description\":\"Brand name drugs that do not have a generic equivalent, but have a therapeutic alternative Preferred brand drug available.\\n\\n- Brand name drugs not usually used as the first line of treatment\\n\\n - Brand name drugs that have a generic equivalent\\n\\n- Second-highest copayment\",\"isNullable\":true,\"name\":\"NonPreferredBrandDrugIndicator\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"SpecialtyDrugIndicator\"},\"dataType\":\"boolean\",\"description\":\"Medications classified by BCBSNC as those that generally have unique uses, require special dosing or administration, are typically prescribed by a specialist provider and are significantly more expensive than alternative drugs or therapies.\",\"isNullable\":true,\"name\":\"SpecialtyDrugIndicator\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"OverTheCounterMedicationIndicator\"},\"dataType\":\"boolean\",\"description\":\"An OTC (over-the-counter) medication is any medication that can be purchased without a prescription. There are OTC medications on the market that effectively treat many common health conditions, including allergies, heartburn, and arthritis.\",\"isNullable\":true,\"name\":\"OverTheCounterMedicationIndicator\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"HabitFormingDrugIndicator\"},\"dataType\":\"boolean\",\"description\":\"Indicates that the drug is habit forming.\",\"isNullable\":true,\"name\":\"HabitFormingDrugIndicator\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"PrescriptionNeededIndicator\"},\"dataType\":\"boolean\",\"description\":\"Indicates that the drug requires a prescription.\",\"isNullable\":true,\"name\":\"PrescriptionNeededIndicator\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"AvailableAsGenericDrugIndicator\"},\"dataType\":\"boolean\",\"description\":\"Indicates that the drug is available as a generic drug.\",\"isNullable\":true,\"name\":\"AvailableAsGenericDrugIndicator\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"NaturalSourcedDrugIndicator\"},\"dataType\":\"boolean\",\"description\":\"A drug defined as a natural product that is obtained from plants, microbes, animal tissues and minerals.\",\"isNullable\":true,\"name\":\"NaturalSourcedDrugIndicator\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"SyntheticDrugIndicator\"},\"dataType\":\"boolean\",\"description\":\"Drugs that are synthesized compounds and modified naturally occurring drugs.\",\"isNullable\":true,\"name\":\"SyntheticDrugIndicator\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"TherapeuticAlternativeDrugIndicator\"},\"dataType\":\"boolean\",\"description\":\"Drug products that provide the same pharmacological or chemical effect in equivalent doses. Also see Formulation Substitution.\",\"isNullable\":true,\"name\":\"TherapeuticAlternativeDrugIndicator\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"SugarFreeProductIndicator\"},\"dataType\":\"boolean\",\"description\":\"Indicates the associated drug/product is sugar-free.\",\"isNullable\":true,\"name\":\"SugarFreeProductIndicator\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"AlcoholFreeProductIndicator\"},\"dataType\":\"boolean\",\"description\":\"Indicates that the associated drug/product is alcohol-free.\",\"isNullable\":true,\"name\":\"AlcoholFreeProductIndicator\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"SulfiteContainingProductIndicator\"},\"dataType\":\"boolean\",\"description\":\"Indicates the associated drug/product contains sulfites.\",\"isNullable\":true,\"name\":\"SulfiteContainingProductIndicator\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"DrugMayCausePhotosensitivityIndicator\"},\"dataType\":\"boolean\",\"description\":\"Indicates the associated drug/product may cause photosensitivity reactions.\",\"isNullable\":true,\"name\":\"DrugMayCausePhotosensitivityIndicator\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"ControlledSubstanceIndicator\"},\"dataType\":\"boolean\",\"description\":\"Indicates that the drug/product is a controlled substance.\",\"isNullable\":true,\"name\":\"ControlledSubstanceIndicator\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"RequiresPrescriptionIndicator\"},\"dataType\":\"boolean\",\"description\":\"Indicates the associated drug/product requires a prescription for purchase.\",\"isNullable\":true,\"name\":\"RequiresPrescriptionIndicator\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"ControlledReleaseProductIndicator\"},\"dataType\":\"boolean\",\"description\":\"Indicates the associated drug/product is a controlled-release product.\",\"isNullable\":true,\"name\":\"ControlledReleaseProductIndicator\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"ControlledDiffusionExtendedReleaseProductIndicator\"},\"dataType\":\"boolean\",\"description\":\"Diffusion drug release may be regulated by means of a rate-controlling membrane.\",\"isNullable\":true,\"name\":\"ControlledDiffusionExtendedReleaseProductIndicator\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"ControlledDissolutionReleaseProductIndicator\"},\"dataType\":\"boolean\",\"description\":\"Dissolution is controlled by means of inert polymers that gradually break down in body fluids.\",\"isNullable\":true,\"name\":\"ControlledDissolutionReleaseProductIndicator\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"OsmoticPressureSustainedReleaseProductIndicator\"},\"dataType\":\"boolean\",\"description\":\"A product containing an osmotic agent that attracts gastrointestinal fluid at a constant rate.  The attracted fluid then forces the drug out of the that tablet through a small laser-drilled orifice.\",\"isNullable\":true,\"name\":\"OsmoticPressureSustainedReleaseProductIndicator\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"DelayedReleaseProductIndicator\"},\"dataType\":\"boolean\",\"description\":\"Indicates the associated drug/product is a delayed-release product.\",\"isNullable\":true,\"name\":\"DelayedReleaseProductIndicator\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"DoNotCrushProductIndicator\"},\"dataType\":\"boolean\",\"description\":\"Indicates the associated drug/product should not be crushed and administered in any other form.\",\"isNullable\":true,\"name\":\"DoNotCrushProductIndicator\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"SelfAdministeredDrugIndicator\"},\"dataType\":\"boolean\",\"description\":\"Drugs that do not require doctors or nurses to help you when you take them. You may be charged for these. You will need to check with your doctor or hospital regarding their policy on this.\",\"isNullable\":true,\"name\":\"SelfAdministeredDrugIndicator\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"EntericCoatedProductIndicator\"},\"dataType\":\"boolean\",\"description\":\"Indicates the associated drug/product is an enteric-coated product.\\n\\nIn general, capsules containing sustained-release or enteric-coated particles may be opened and their contents administered on a spoonful of soft food.\",\"isNullable\":true,\"name\":\"EntericCoatedProductIndicator\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"SlowReleaseProductIndicator\"},\"dataType\":\"boolean\",\"description\":\"Indicates the associated drug/product is a slow-release product.\",\"isNullable\":true,\"name\":\"SlowReleaseProductIndicator\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"TimedReleaseProductIndicator\"},\"dataType\":\"boolean\",\"description\":\"Indicates the associated drug/product is a timed-release product.\",\"isNullable\":true,\"name\":\"TimedReleaseProductIndicator\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"EssentialDrugProductIndicator\"},\"dataType\":\"boolean\",\"description\":\"Essential drugs are those that satisfy the health care needs of the majority of the population.\",\"isNullable\":true,\"name\":\"EssentialDrugProductIndicator\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"FinishedProductIndicator\"},\"dataType\":\"boolean\",\"description\":\"A product that has undergone all stages of production, including packaging in its final container and labeling.\",\"isNullable\":true,\"name\":\"FinishedProductIndicator\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"PharmaceuticalProductIndicator\"},\"dataType\":\"boolean\",\"description\":\"Any preparation for human or veterinary use that is intended to modify or explore physiological systems or pathological states for the benefit of the recipient.\",\"isNullable\":true,\"name\":\"PharmaceuticalProductIndicator\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"LactoseFreeProductIndicator\"},\"dataType\":\"boolean\",\"description\":\"Indicates that the product is lactose-free.\",\"isNullable\":true,\"name\":\"LactoseFreeProductIndicator\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"AgonistDrugIndicator\"},\"dataType\":\"boolean\",\"description\":\"Drugs that have both receptor affinity and intrinsic activity are called agonists.\",\"isNullable\":true,\"name\":\"AgonistDrugIndicator\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"AntagonistDrugIndicator\"},\"dataType\":\"boolean\",\"description\":\"Drugs that have receptor affinity but lack intrinsic activity are called antagonists.\",\"isNullable\":true,\"name\":\"AntagonistDrugIndicator\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"GalactoseFreeProductIndicator\"},\"dataType\":\"boolean\",\"description\":\"Indicates that the product is lactose-free.\",\"isNullable\":true,\"name\":\"GalactoseFreeProductIndicator\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"CholinergicReceptorAgonistDrugIndicator\"},\"dataType\":\"boolean\",\"description\":\"Cholinergic means related to the neurotransmitter acetylcholine,  and is typically used in a neurological perspective. \\n\\nThe parasympathetic nervous system  is entirely cholinergic. Neuromuscular junctions, preganglionic neurons of the sympathetic nervous system, the basal forebrain, and brain stem complexes are also cholinergic. \\n\\nIn addition, the receptor for the merocrine sweat glands are also cholinergic since acetylcholine is released from post ganglionic sympathetic neurons.\",\"isNullable\":true,\"name\":\"CholinergicReceptorAgonistDrugIndicator\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"CholinergicReceptorAntagonistDrugIndicator\"},\"dataType\":\"boolean\",\"description\":\"The majority of the drugs used to reduce the effects of acetylcholine inhibit specifically certain types of acetylcholine receptors and can be named cholinolytic or cholinergic antagonists. \\n\\nOthers inhibit acetylcholine release at the synaptic level.\",\"isNullable\":true,\"name\":\"CholinergicReceptorAntagonistDrugIndicator\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"AdrenergicReceptorAgonistDrugIndicator\"},\"dataType\":\"boolean\",\"description\":\"The adrenergic receptors (or adrenoceptors) are a class of G protein-coupled receptors that are targets of the catecholamines, especially noradrenaline (norepinephrine) and adrenaline (epinephrine). Although dopamine  is a catecholamine, its receptors are in a different category.\\n\\nMany cells possess these receptors, and the binding of an agonist will generally cause a sympathetic response (e.g. the fight-or-flight response). For instance, the heart rate will increase and the pupils will dilate, energy will be mobilized, and blood flow diverted from other non-essential organs to skeletal muscle.\",\"isNullable\":true,\"name\":\"AdrenergicReceptorAgonistDrugIndicator\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"AdrenergicReceptorAntagonistDrugIndicator\"},\"dataType\":\"boolean\",\"description\":\"An Adrenergic antagonist is a pharmaceutical substance that acts to inhibit the action of the adrenergic receptors. It is thus a type of sympatholytic.\\n\\nIt has the opposite effect as adrenergic agonists.\",\"isNullable\":true,\"name\":\"AdrenergicReceptorAntagonistDrugIndicator\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"AntihypertensiveDrugIndicator\"},\"dataType\":\"boolean\",\"description\":\"Drugs that combat hypertension.\\n\\nThese are classified as:\\n-  Diuretics\\n-  Sympatholytics\\n-  Angiotensin Inhibitors\\n-  Vasodilators\",\"isNullable\":true,\"name\":\"AntihypertensiveDrugIndicator\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"DiureticDrugIndicator\"},\"dataType\":\"boolean\",\"description\":\"Diuretics cause an increase in renal sodium excretion to reduce blood pressure.\",\"isNullable\":true,\"name\":\"DiureticDrugIndicator\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"AntianginalDrugIndicator\"},\"dataType\":\"boolean\",\"description\":\"Antianginal drugs seek to restore the balance between myocardial oxygen supply and demand,, either by increasing oxygen supply or decreasing oxygen demand.\\n\\nAntianginal drugs are classified as:\\n- Vasodilators\\n- Beta-Adrenergic Receptor Antagonists\",\"isNullable\":true,\"name\":\"AntianginalDrugIndicator\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"AntiarrhythmicDrugIndicator\"},\"dataType\":\"boolean\",\"description\":\"Antiarrhythmic drugs help control or moderate the heartbeats.\\n\\nThey are classified as:\\n-  Sodium Channel Blockers Class 1\\n-  Sodium Channel Blockers Class 1A\\n-  Sodium Channel Blockers Class 1B\\n-  Sodium Channel Blockers Class 1C\\n-  Sodium Channel Blockers Class II\\n-  Sodium Channel Blockers Class III\\n-  Sodium Channel Blockers Class IV\",\"isNullable\":true,\"name\":\"AntiarrhythmicDrugIndicator\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"HyperlipidemiaDrugIndicator\"},\"dataType\":\"boolean\",\"description\":\"Hyperlipidemia drugs are used control cholesterol.\",\"isNullable\":true,\"name\":\"HyperlipidemiaDrugIndicator\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"HematopoieticDrugIndicator\"},\"dataType\":\"boolean\",\"description\":\"Hematopoietic drugs address anemia or similar blood deficiencies.\",\"isNullable\":true,\"name\":\"HematopoieticDrugIndicator\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"AnticoagulantDrugIndicator\"},\"dataType\":\"boolean\",\"description\":\"An anticoagulant is a substance that prevents coagulation; that is, it stops blood from clotting.\",\"isNullable\":true,\"name\":\"AnticoagulantDrugIndicator\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"AntiplateletDrugIndicator\"},\"dataType\":\"boolean\",\"description\":\"An antiplatelet drug is a member of a class of pharmaceuticals  that decreases platelet aggregation and inhibits thrombus formation\",\"isNullable\":true,\"name\":\"AntiplateletDrugIndicator\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"FibrinolyticDrugIndicator\"},\"dataType\":\"boolean\",\"description\":\"Fibrinolysis is the process wherein a fibrin clot, the product of coagulation, is broken down.\\n\\nIts main enzyme  plasmin  cuts the fibrin mesh at various places, leading to the production of circulating fragments that are cleared by other proteases  or by the kidney  and liver.\",\"isNullable\":true,\"name\":\"FibrinolyticDrugIndicator\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"SedativeHypnoticAnxiolyticDrugIndicator\"},\"dataType\":\"boolean\",\"description\":\"A sedative is a drug that reduces a persons response to external stimuli and causes drowsiness.\\n\\nA hypnotic drug is a sedative that induces sleep.\",\"isNullable\":true,\"name\":\"SedativeHypnoticAnxiolyticDrugIndicator\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"AntiepilepticDrugIndicator\"},\"dataType\":\"boolean\",\"description\":\"Antiepileptic drugs are medicines that reduce the frequency of epileptic  seizures.\",\"isNullable\":true,\"name\":\"AntiepilepticDrugIndicator\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"NeurodegenerativeDrugIndicator\"},\"dataType\":\"boolean\",\"description\":\"Neurodegeneration is the umbrella term for the progressive loss of structure or function of neurons, including death of neurons.\\n\\nMany neurodegenerative diseases including Parkinson's, Alzheimer's, and Huntington's occur as a result of neurodegenerative processes.\",\"isNullable\":true,\"name\":\"NeurodegenerativeDrugIndicator\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"PsychotherapeuticDrugIndicator\"},\"dataType\":\"boolean\",\"description\":\"Drugs that address psychiatric disorders such as schizophrenia.\",\"isNullable\":true,\"name\":\"PsychotherapeuticDrugIndicator\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"OpioidAnalgesicDrugIndicator\"},\"dataType\":\"boolean\",\"description\":\"An opioid is a chemical that works by binding to opioid receptors, which are found principally in the central nervous system and the gastrointestinal tract. \\n\\nThe receptors in these two organ systems mediate both the beneficial effects and the side effects of opioids.\",\"isNullable\":true,\"name\":\"OpioidAnalgesicDrugIndicator\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"LocalAnestheticDrugsIndicator\"},\"dataType\":\"boolean\",\"description\":\"Local anesthesia is any technique to render part of the body insensitive to pain  without affecting consciousness.\",\"isNullable\":true,\"name\":\"LocalAnestheticDrugsIndicator\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"GeneralAnestheticDrugsIndicator\"},\"dataType\":\"boolean\",\"description\":\"A general anesthesia is a state of total unconsciousness resulting from general anesthetic drugs\",\"isNullable\":true,\"name\":\"GeneralAnestheticDrugsIndicator\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"RespiratoryTractDisorderDrugIndicator\"},\"dataType\":\"boolean\",\"description\":\"A drug addressing disorders of the respiratory tract such as asthma, chronic obstructive pulmonary disease, allergic rhinitis, virial rhinitis etc.\",\"isNullable\":true,\"name\":\"RespiratoryTractDisorderDrugIndicator\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"GastrointestinalTractDisorderDrugIndicator\"},\"dataType\":\"boolean\",\"description\":\"Functional disorders are those in which the bowel looks normal but doesn't work properly. They are the most common problems affecting the colon and rectum.\",\"isNullable\":true,\"name\":\"GastrointestinalTractDisorderDrugIndicator\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"HeadacheDisorderDrugIndicator\"},\"dataType\":\"boolean\",\"description\":\"Drugs used to address headaches.\",\"isNullable\":true,\"name\":\"HeadacheDisorderDrugIndicator\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"PainInflammationDrugIndicator\"},\"dataType\":\"boolean\",\"description\":\"Drug used to control inflammation and pain.\",\"isNullable\":true,\"name\":\"PainInflammationDrugIndicator\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"ArthriticDisorderDrugIndicator\"},\"dataType\":\"boolean\",\"description\":\"Arthritis is a joint disorder featuring inflammation. A joint is an area of the body where two different bones meet. A joint functions to move the body parts connected by its bones. Arthritis literally means inflammation of one or more joints.\",\"isNullable\":true,\"name\":\"ArthriticDisorderDrugIndicator\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"HypothalamicPituitaryDrugIndicator\"},\"dataType\":\"boolean\",\"description\":\"The hypothalamus can be considered the coordinating center of the endocrine system. It consolidates signals derived from upper cortical inputs, autonomic function, environmental cues such as light and temperature, and peripheral endocrine feedback. In turn, the hypothalamus delivers precise signals to the pituitary gland which then releases hormones that influence most endocrine systems in the body.\",\"isNullable\":true,\"name\":\"HypothalamicPituitaryDrugIndicator\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"ThyroidDrugIndicator\"},\"dataType\":\"boolean\",\"description\":\"he thyroid gland is located on the front part of the neck below the thyroid cartilage.\\n\\nThe gland produces thyroid hormones, which regulate body metabolism. Thyroid hormones are important in regulating body energy, the body's use of other hormones and vitamins, and the growth and maturation of body tissues.\",\"isNullable\":true,\"name\":\"ThyroidDrugIndicator\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"AdrenalSteroidDrugIndicator\"},\"dataType\":\"boolean\",\"description\":\"The adrenal cortex is a factory for steroid hormones. In total, at least two to three dozen different steroids are synthesized and secreted from this tissue, but two classes are of particular importance.\\n\\nAdditionally, the adrenal cortex produces some sex steroids, particularly androgens, a talent of considerable importance in such diseases as congenital adrenal hyperplasia.\\n\\nLike all steroids, adrenal \\\"corticosteroids\\\" are synthesized from cholesterol through a series of enzyme-mediated transformations.\",\"isNullable\":true,\"name\":\"AdrenalSteroidDrugIndicator\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"FertilityReproductionDrugIndicator\"},\"dataType\":\"boolean\",\"description\":\"Drug used for fertility and reproduction diseases and dysfunctions.\",\"isNullable\":true,\"name\":\"FertilityReproductionDrugIndicator\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"DiabetesMellitusDrugIndicator\"},\"dataType\":\"boolean\",\"description\":\"Diabetes is a condition in which a person has a high blood sugar (glucose) level, either because the body doesn't produce enough insulin, or because body cells don't properly respond to the insulin that is produced. \\n\\nInsulin is a hormone produced in the pancreas  which enables body cells to absorb glucose, to turn into energy. If the body cells do not absorb the glucose, the glucose accumulates in the blood (hyperglycemia), leading to vascular, nerve, and other complications.\",\"isNullable\":true,\"name\":\"DiabetesMellitusDrugIndicator\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"CalciumAndBoneDrugIndicator\"},\"dataType\":\"boolean\",\"description\":\"Indicates whether the drug is used to treat conditions involving calcium and bone.\",\"isNullable\":true,\"name\":\"CalciumAndBoneDrugIndicator\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"AntimycobacterialDrugIndicator\"},\"dataType\":\"boolean\",\"description\":\"An antimycobacterial is a type of drug used to treat Mycobacteria infections.\",\"isNullable\":true,\"name\":\"AntimycobacterialDrugIndicator\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"AntibacterialDrugIndicator\"},\"dataType\":\"boolean\",\"description\":\"A drug that destroys bacteria or suppresses their growth or their ability to reproduce.\",\"isNullable\":true,\"name\":\"AntibacterialDrugIndicator\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"AntifungalDrugIndicator\"},\"dataType\":\"boolean\",\"description\":\"An antifungal drug is a medication used to treat fungal infections  such as athlete's foot, ringworm, candidacies, serious systemic infections such as cryptococcal  meningitis, and others.\",\"isNullable\":true,\"name\":\"AntifungalDrugIndicator\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"AntiviralDrugIndicator\"},\"dataType\":\"boolean\",\"description\":\"Antiviral drugs are a class of medication used specifically for treating viral infections.\",\"isNullable\":true,\"name\":\"AntiviralDrugIndicator\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"AntiparasiticDrugIndicator\"},\"dataType\":\"boolean\",\"description\":\"Antiparasitics are a class of medications which are indicated for the treatment of parasitic diseases such as nematodes, cestodes, trematodes, infectious protozoa, and amoebas.\",\"isNullable\":true,\"name\":\"AntiparasiticDrugIndicator\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"AntineoplasticImmunomodulatingDrugIndicator\"},\"dataType\":\"boolean\",\"description\":\"Antineoplastics are drugs that inhibit and combat the development of neoplasms.\",\"isNullable\":true,\"name\":\"AntineoplasticImmunomodulatingDrugIndicator\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"DrugTypeId\"},\"dataType\":\"integer\",\"description\":\"The unique identifier of a Drug type.\",\"isNullable\":true,\"name\":\"DrugTypeId\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"DoseFormId\"},\"dataType\":\"integer\",\"description\":\"The unique identifier of a drug dose form.\",\"isNullable\":true,\"name\":\"DoseFormId\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"AdministrationRouteId\"},\"dataType\":\"integer\",\"description\":\"The unique identifier of the route, means or method of administering the associated drug/pharmaceutical product.\",\"isNullable\":true,\"name\":\"AdministrationRouteId\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"PackageTypeId\"},\"dataType\":\"integer\",\"description\":\"The unique identifier of a Package Type.\",\"isNullable\":true,\"name\":\"PackageTypeId\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"ControlledSubstanceClassId\"},\"dataType\":\"integer\",\"description\":\"The unique identifier of a Controlled Substance Class.\",\"isNullable\":true,\"name\":\"ControlledSubstanceClassId\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"MarketingStatusId\"},\"dataType\":\"integer\",\"description\":\"The unique identifier of a drug Marketing Status.\",\"isNullable\":true,\"name\":\"MarketingStatusId\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"AbsorptionMethodId\"},\"dataType\":\"integer\",\"description\":\"The unique identifier of an Absorption Method.\",\"isNullable\":true,\"name\":\"AbsorptionMethodId\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"BiotransformationPhaseId\"},\"dataType\":\"integer\",\"description\":\"The unique identifier of a Biotransformation Phase.\",\"isNullable\":true,\"name\":\"BiotransformationPhaseId\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"ExcretionMethodId\"},\"dataType\":\"integer\",\"description\":\"The unique identifier of an Excretion Method.\",\"isNullable\":true,\"name\":\"ExcretionMethodId\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"DrugClassId\"},\"dataType\":\"integer\",\"description\":\"The unique identifier of a Drug Class.\",\"isNullable\":true,\"name\":\"DrugClassId\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"PregnancyCategoryId\"},\"dataType\":\"integer\",\"description\":\"The unique identifier of a Pregnancy Category.\",\"isNullable\":true,\"name\":\"PregnancyCategoryId\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"UscId\"},\"dataType\":\"integer\",\"description\":\"The unique identifier of the USC.\",\"isNullable\":true,\"name\":\"UscId\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"DrugReleaseTypeId\"},\"dataType\":\"integer\",\"description\":\"The unique identifier of a Drug Release Type.\",\"isNullable\":true,\"name\":\"DrugReleaseTypeId\"},{\"type\":\"Existing\",\"attributeReference\":{\"entity\":\"Drug.cdm.json/Drug\",\"name\":\"DrugCategoryId\"},\"dataType\":\"integer\",\"description\":\"The unique identifier of a Drug Category.\",\"isNullable\":true,\"name\":\"DrugCategoryId\"}]}}}",
			"Description": "A Pharmaceutical 'product' is a product that has undergone all stages of production, including packaging in its final container and labeling.  It is a good or item capable of satisfying a need or a want that is offered to a target market for attention, acquisition, use or consumption.      \n\nThe finished dosage form that contains a drug substance, generally, but not necessarily in association with other active or inactive ingredients. \n\nA drug is defined as: \n- A substance recognized by an official pharmacopoeia or formulary. \n\n- A substance intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease. \n\n- A substance (other than food) intended to affect the structure or any function of the body. \n\n- A substance intended for use as a component of a medicine but not a device or a component, part or accessory of a device. \n\nA product number is assigned to each drug product associated with an NDA (New Drug Application).  If a drug product is available in multiple strengths, there are multiple product numbers.\n\nBiologic products are included within this definition and are generally covered by the same laws and regulations, but differences exist regarding their manufacturing processes (chemical process vs. biological process.) \n\nA finished dosage form (e.g. tablet, capsule, or solution) that contains the active drug ingredient usually combined with inactive ingredients.\n\nEach product has its own benefits, quality, brand name, and packaging that gives it its own identity and distinguishing characteristics.  \n\nEvery business or organization has business rules that define precisely what a product is.    While we intuitively know what a product is, we must quantify that knowledge and associated business rules so that consistent applications can be developed.\n\nA product typically goes through five stages of development:\n\n(1)  Idea Stage - involving a thorough evaluation of the potential product\n\n(2)  Concept Stage - determines customer acceptance by testing and presentation to consumers and distribution channel members.   Specific aspects regarding quality, dependability, reliability, warranty, packaging, service, pricing, terms of sale, sales and distribution channels, advertising and promotions are evaluated.\n\n(3)  Product Development Stage - transforms the prototype product into an actual product for mass sale.   This stage requires close interaction between both marketing and manufacturing.\n\n(4)  Test Marketing Stage - may or may not be used since it is an expensive and time-consuming process.  Test marketing involves evaluating various product options and alternatives.\n\n(5)  Commercialization - It is very expensive to launch a new product so commercialization only applies to those specific products that are actually going to be sold to the market.",
			"DisplayFolderInfo": "{\"name\":\"Product\",\"colorCode\":\"#4B003F\"}",
			"PrimaryKeys": "DrugId",
			"spark.sql.sources.provider": "csv",
			"sql:IsAppendOnly": false
		},
		"Retention": 0,
		"Temporary": false,
		"IsRewriteEnabled": false
	},
	"type": "TABLE"
}